Toward an Understanding of How Hypercapnia Affects Apoptosis in Human Promyeloblasts in 3D Suspension Culture Systems by Hamad, Mouna
  
 
 
 
TOWARD AN UNDERSTANDING OF HOW 
HYPERCAPNIA AFFECTS APOPTOSIS IN 
HUMAN PROMYELOBLASTS IN 3D 
SUSPENSION CULTURE SYSTEMS 
 
BY 
MOUNA HAMAD 
 
A DISSERTATION SUBMITTED IN FULFILMENT OF THE  
REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY 
 
AT 
THE SCHOOL OF CHEMICAL AND BIOMOLECULAR ENGINEERING 
THE UNIVERSITY OF SYDNEY 
2017
I 
 
Declaration Statement 
I declare that the work presented in this dissertation is original and the product of my own 
work except as acknowledged throughout the text.   
This work has not been submitted for a degree at any other university. 
This thesis contains materials published in (1), in which I am leading author, and is distributed 
throughout the thesis. 
 
 
Mouna Hamad 
February, 2017 
 
 
 
 
 
 
 
 
 
 
 
 
 
II 
 
Acknowledgments 
First and foremost, I would like to thank God almighty, the Most Gracious, the Most Merciful, 
for granting me the knowledge and the ability to complete my PhD studies.  
I would like to express my sincere gratitude and appreciation to my supervisor A/Prof Ali 
Abbas for his ongoing support and encouragement towards my research. Thank you Ali for 
your patience and understanding in all circumstances, thank you for your continuous 
enthusiasm and motivation, thank you for pushing me and allowing me to grow as a research 
scientist. I mostly appreciate you persuading me to present my work at numerous 
conferences/seminars/competitions and to meet new people, my experience has truly been 
valuable and much more than I ever imagined. I am also very grateful for your advice on both 
my research as well as on my future career, your immense knowledge and guidance was 
priceless. Finally, thank you for your assistance towards the publishing of this thesis document; 
it would not have been possible otherwise. 
Huge thanks to my co-supervisor Dr Mohammad R. Irhimeh for his immense help in my 
integration into the cell world. Thank you Mohammad for teaching me all I need to know about 
cells and cell culturing and also for providing us with the cell line used throughout this project, 
it would not have been possible without your time and efforts. 
I would also like to thank the School of Chemical and Biomolecular Engineering at the 
University of Sydney; it has been a pleasure being part of such a wonderful and warm 
community. Special thanks to the beautiful ladies in the office, Annette Karydis, Agnes 
Constanti, and Lynne, for always being welcoming and ready to help with a smile. Thank you 
to the beautiful Elizabeth Dobrinsky for our chats and giggles. Thank you to Sergio Londono 
and Bogumil Eichstaedt for all their help in the lab, I greatly appreciate your time and 
assistance. 
Thanks to all my colleagues that I have met over the years for your help in one way or another: 
Harry Manoli, Muhamad Hafiz Abd Rahim, Hari Jeyaseelan, Eleonora Costamagna, Edoardo 
Bartolini, and all the PhD students in our postgraduate office. It was a pleasure being part of 
the team, and congratulations to all those who graduated. 
III 
 
Thank you to everyone within the Bosch facilities who made this project possible, Donna Lai, 
Sheng Hua, Angeles Sanchez-Perez, and Xiaosuo Wang. Special thanks to Angeles for the 
great amount of help and time she dedicated towards mentoring me in the flow cytometry 
section of this project. Thanks to Adrian Smith and Caroline Royle from the Centenary 
Institute for their assistance also in the flow cytometry. 
I must also acknowledge the School of Chemistry at the University of Sydney, thank you for 
being my second family over the last several years and hopefully for many more to come. 
Thank you to Dr Ron Clarke, Dr Robert Baker, and Jeanette Hurst for the opportunity to be 
part of your community. Thanks to all the demo’s for being wonderful family, especially Peter 
Luke for the wonderful morning whistles! Huge thanks to the beautiful Sophie Patsalides and 
Marjan Ashna for your support and kindness especially during my pregnancy. 
Very special thanks to my one and only friend Mengyu Wang. Mengyu, thank you for being 
the most wonderful, kind-hearted, amazing friend and office-neighbour anyone can ask for. 
Thank you for listening to my complaints and always making me feel better. Thank you for 
your very wise words and suggestions in all the times I needed to hear them. Thank you for our 
coffee-getaways which always made my days brighter. Thanks for your delicious drawer which 
was always full of yummy-ness. I cannot thank you enough for being a friend I will love and 
cherish forever, you made my PhD journey much more valuable. Congratulations on also 
finishing your PhD, cannot wait to graduate together!!  
To my beloved family... Thank you to my dad who always believed in me and encouraged me, 
thanks for always showing me how proud you are of what I have achieved. I appreciate all 
your dedications towards helping reach this goal. Thank you to my brother Ahmed for all your 
support and for being my wonderful lab buddy during all holidays, I appreciate all the time you 
spent by my side, I would not have done it without you! Thank you to my brother Ibrahim for 
being a brilliant role model, I admire what you have achieved in your life thus far and wish you 
all the best for all to come. 
To my dear husband Ahmad, I cannot thank you enough! Thank you for being there for me all 
throughout my candidature. Thanks for putting up with me in all my moods and for always 
giving me a shoulder to lean on during this rollercoaster. Thanks for your ongoing support, 
IV 
 
your encouragement, and most importantly, your love. You are an amazing friend and husband, 
and now an even more wonderful father. I could not have become who I am today without you! 
Last, but certainly not least, I would like to express my deepest sense of gratitude to my 
beloved mother. Mum, I am more than thankful for you. If it weren’t for you, I would not have 
even applied to continue my postgraduate studies. Thank you for always encouraging and 
motivating me to do better. Thank you for your patience and for your infinite help throughout 
all my years. Thank you for being the most remarkable role model both as a mother and as a 
teacher. Thank you for being my best friend and for making me the woman I am today. I 
continue to learn from you how to be a better person and a better mother every day. Thank you 
for simply being there for me, none of this would be possible without you! 
To my baby Hussain, thank you for coming into this world and making my life so much more 
cheerful and meaningful. It was a tough ride for the two of us, but your infectious smile made 
every day a lot more bearable and brighter.  My heart is an ocean and it is full of love for you 
habibi, this is all for you! 
 
 
 
 
 
 
 
 
 
 
 
V 
 
Preface 
Basic biology teaches us that humans and all human cells breathe in oxygen and discard carbon 
dioxide. We are also taught that excessive amounts of carbon dioxide are detrimental to all 
human life forms. Hence the vast majority, in fact almost all, of human cell-related researches 
focus on carbon dioxide as the ‘bad guy’, the byproduct, the contaminant, or the toxin that 
must be eliminated from the cell culture system to prevent unfavourable effects upon the cells 
in focus. However, it must be highlighted that an immeasurable count of studies have and are 
currently being conducted on human stem cells. Stem cells are born within the human bone 
marrow and they exist in this environment for quite some time before differentiating and 
committing to a specific lineage and leaving for their destined site in the body. Nowhere in the 
literature is it stated that in the bone marrow these early stem cells exclusively breathe in 
oxygen, nor is it stated that these stem cells utterly rely on oxygen for their optimal 
proliferation and/or pluripotency. Nowhere in the literature is it demonstrated that carbon 
dioxide is a ‘contaminant’ or ‘toxin’ in the bone marrow which hinders stem cell proliferation 
capacity and must be eliminated. It seems, to the best of my knowledge, that researchers do not 
have any clear idea of the precise gas composition, specifically carbon dioxide, within the bone 
marrow niches which ensures an optimum microenvironment for stem cell proliferation and 
development.  
Oxygen concentrations, on the other hand, have been researched much more than carbon 
dioxide to optimise in vitro culture conditions of bone marrow progenitor cells. It is now well 
known that a hypoxic environment is maintained within the bone marrow where oxygen 
tension ranges from 1 to 6% (2, 3). Human blood contains dissolved carbon dioxide at a 
concentration close to 5% (40 mmHg), but this is very different from the environment 
surrounding progenitor stem cells such as hematopoietic stem cells in vivo within bone marrow 
niches (3, 4). Very little evidence is present to provide a rationale for choosing this 
concentration (5%) of carbon dioxide for culturing progenitor cells of the bone marrow in vitro. 
Despite current literature not accurately defining the distribution of carbon dioxide in the bone 
marrow niches, it is nevertheless well established that the 5% carbon dioxide concentration 
used in standard cell culturing is lower than that surrounding the bone marrow-hematopoietic 
stem cells (3, 5). Only a few studies have been conducted on the effect of carbon dioxide on 
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mammalian stem cells and results are contradictory with some cell types favouring 
hypercapnia and others hypocapnia (high and low concentrations of carbon dioxide, 
respectively).  
So we questioned... Why are stem cells in the literature always cultured at 5% carbon dioxide? 
Why is carbon dioxide completely overlooked in stem cell research altogether? Why is oxygen 
the primary gas examined in terms of stem cell proliferation? What if carbon dioxide played a 
critical role within the bone marrow microenvironment to ensure stem cell aptness? What if 
carbon dioxide is not the ‘bad guy’ after all?  
Our hypothesis is that, similarly to oxygen, carbon dioxide is also involved in key role(s) in the 
proliferation and/or development of human stem cells. Whether progenitor stem cells favour 
carbon dioxide concentrations higher or lower than the commonly renowned 5% is the main 
broad topic of this thesis. From the above perspective, the thesis herein will examine the effects 
of hypo- and hypercapnia on human promyeloblasts, specifically focusing on the apoptotic 
capacity of these cells in this regard. Concurrently, the effect of the culture environment itself 
will also be scrutinized (two dimensional flasks versus a three dimensional stirred suspension 
bioreactor).  
This study analyses the effects of hypo- and hypercapnia using the cell line KG-1a to model 
human hematopoietic stem cells. This is a reasonable assumption to make, given that both KG-
1a and human hematopoietic stem cells express the CD34
+
 antigen and have analogous 
properties. To the best of our knowledge, this work is novel since no other research has 
described the optimization of KG-1a cell expansion under varying concentrations of dissolved 
carbon dioxide, nor has the apoptotic profile of these cells, or any other mammalian cell/cell 
line, been focused on in this manner. We firmly believe this work will significantly contribute 
towards innovative stem cell culturing methods and towards a better understanding of the in 
vivo microenvironment of hematopoietic stem cells. 
This dissertation presents 6 chapters. Chapter 1 will introduce the reader to stem cells and their 
current use in research/therapy with specific focus on hematopoietic stem cells and their role 
towards the treatment of leukaemia. This chapter will also emphasise the importance of carbon 
dioxide in mammalian cell culture, particularly in the apoptosis cascade. Chapter 2 will review 
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the role of carbon dioxide in the hematopoietic stem cell microenvironment and the expansion 
of mammalian stem cells in hypo- and/or hypercapnic conditions. It will also review in detail 
conventional 2D culture methods versus 3D bioreactor culture systems and related 
configurations and parameters with specific focus on the various bioreactor systems used in the 
literature for the expansion of hematopoietic stem cells. Chapter 3 will discuss our 
experimental materials and methods in detail. The experimental work conducted will then be 
portrayed and results discussed in Chapters 4 and 5, respectively, then in Chapter 6 relevant 
conclusions and future recommendations will be made. This thesis will also provide a concise 
literature review on the culturing of hematopoietic stem cells in model-based controlled 3D 
culture systems. Since this review is slightly beyond the main scope of our work, it will be 
presented at the end of the dissertation for the reader’s expediency. The purpose of the latter 
review is to provide the reader with an indication of where the literature currently stands with 
respect to the expansion of hematopoietic stem cells in controlled 3D systems, which will, in 
turn, give insight into the future potential(s) of our own work presented herein. 
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Abstract 
Stem cells have more recently attracted interest in scientific research and their use is increasingly 
developing in many therapeutic fields and applications (6, 7), such as cell transplantation therapy 
(8), cardiac cell therapy (6), genetic manipulation studies (7), tissue differentiation/regeneration 
(9), and many more. Culturing stem cells, however, is a complex challenge particularly at the 
clinical scale where there are critical shortages. In this regard, the establishment of an in vitro 
environment near-identical to that of the in vivo bone marrow one is of significant interest, 
particularly if such system can also be readily controlled and/or optimised. The body has 
numerous types of cells, all growing in varying conditions of gas distribution, nutrients, blood 
flow, growth surface(s), pH, and temperature. For instance, hematopoietic stem cells are found in 
both the blood and the bone marrow; nevertheless, the microenvironment differs greatly between 
the two sites. Human blood has a maintained dissolved carbon dioxide concentration close to 5% 
(40 mmHg), which is very different from the environment surrounding hematopoietic stem cells 
in vivo within niches.  
A great deal of cell-based work, as evidenced in the literature, is conducted at 5% carbon dioxide 
concentration and is predominantly cultured on flat two-dimensional surfaces (e.g. T-flasks, well 
plates). These protocols and methods are straightforward, simple to handle, and of low economic 
costs. They however do not necessarily replicate the niche microenvironment and are limited in 
terms of gas exchange which is only permissible at the medium surface, and uncontrolled 
concentration gradients are very likely to occur in the medium itself, while experimental 
replications are not guaranteed. It is therefore a major challenge to replicate the real 
microenvironment in vitro with new systems that control parameters such as, carbon 
dioxide/oxygen concentrations, nutrient levels, pH and others. Three dimensional apparatus on 
the other hand allow increased volume space for the cells to grow in and more adequately 
resemble the in vivo environment of cells. In order for stem cells to be considered for successful 
therapeutic use, the in vitro expansion of these cells must be satisfactory, and this will require 3D 
mimicking of the stem cell niche microenvironments, including the replication and control of 
carbon dioxide concentration.  
The stem cell niche microenvironment variables (oxygen/carbon dioxide tension, nutrients, 
proteins, pH, temperature...) directly manipulate stem cell proliferation, differentiation, and 
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apoptotic capacity. Besides oxygen, dissolved carbon dioxide in mammalian cells is equally 
significant, but has been rather disregarded throughout the literature. Humidified cell incubators 
are generally maintained at 5% carbon dioxide in air in the vast majority of hematopoietic stem 
cell-related proliferation studies. Evidence to provide justification for selecting this specific 
concentration of carbon dioxide in hematopoietic progenitor cell proliferation studies is lacking. 
The literature does not currently define the precise distribution of carbon dioxide within niches, 
it is however established that the 5% used for typical cell proliferation is lower than that actually 
encircling hematopoietic stem cells in human tissue. In mammalian cells, carbon dioxide is 
essential but the precise role of carbon dioxide in cell culture is intricate because it can exist in 
many forms and can be regarded as both a nutrient and a potentially inhibitory byproduct. Hence, 
both build-up and excessive removal are unfavourable.  
Hypotheses 
This thesis pursues to prove the following hypotheses: 
i. Hypercapnia decelerates proliferation rate but increases overall expansion of 
hematopoietic progenitor stem cells (KG-1a) without disturbing cell surface integrity. 
ii. Apoptosis of KG-1a cells is delayed under the effect of hypercapnia in both 2D and 3D 
culture systems. 
iii. KG-1a cells can successfully proliferate within a 3D bioreactor culture system to yield 
higher cell concentrations than 2D systems. 
To examine the above hypotheses, the following steps were undertaken:  
i. Assess the proliferation, morphology, apoptotic capacity of KG-1a cells in 2D culture 
systems. 
ii. Research, design, and manufacture of a suitable bioreactor to carry out 3D studies in. 
iii. Set up 3D culture system comprised of: online monitoring and control circuit and feeding 
circuit. 
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iv. Assess the proliferation, morphology, apoptotic capacity, cell surface antigen integrity, 
pH, and metabolism of KG-1a cells in 3D culture system. 
Results 
Experiment 1 revealed that both hypo- and hypercapnia had no substantial effect on 
hematopoietic stem cell-morphology in terms of cell shape and size. Also hypercapnia decreased 
proliferation rate but extended survival, where apoptosis was delayed. Cells also reached higher 
cell concentrations in hypercapnic conditions (15% carbon dioxide in air) in comparison to the 
5% carbon dioxide control and 1% hypocapnic cells. The hypocapnic conditions (1% carbon 
dioxide in air), although increased the cell population doubling time, decreased the maximum 
cell concentration reached over time in comparison to both the control and the hypercapnic cells. 
Hence, having cells which cycle at a slower rate would be favourable for sustaining survival and 
for mimicking the in vivo environment where it is established that cells proliferate at a gradual 
pace. 
In Experiment 2, results showed that both hypo- and hypercapnia had no considerable effect on 
cell morphology in terms of cell size. However, flow cytometry analysis revealed that 
hypocapnia decreased the expression of the CD34
+
 surface antigen, the latter being unaffected by 
hypercapnia with respect to the control populations. Once again, hypercapnia also yielded a 
higher maximum cell concentration, but this was reached later in time compared to the other 
populations. Proliferation was slowest in hypocapnic populations (highest population doubling 
time) despite these cell populations reaching maximum cell concentration in the shortest time. 
According to apoptosis, hypercapnia clearly delayed the progress of apoptosis in the KG-1a 
cells, and vice versa for the hypocapnic cells, confirming results from Experiment 1. This is also 
parallel to the glucose depletion studies, where the cells that cycled slower (hypercapnic) 
metabolized glucose at a respectively slower rate and cells that cycled faster (hypocapnic) 
metabolized glucose at a much faster rate. Therefore, cells which cycle at a slower rate are 
favourable for sustaining survival and delaying apoptosis. This also aligns with in vivo 
environment where it is well established that cells expand at gradual paces.  
In comparing the hypercapnic component of Experiments 1 and 2, it can be seen that 15% carbon 
dioxide in air had an analogous effect on KG-1a cells regardless of the culture system (2D or 
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3D). Cell size in both cultures is almost equivalent and maximum cell number at approximately 
the same time in both 2D and 3D cultures (168 hours and 166 hours, respectively) is comparable: 
5.09  106  3.13  105 and 4.18  106  3.51  104, respectively. The % specific apoptosis is 
however lower in the 3D culture system (-0.68 vs. -0.06), accompanied by a lower population 
doubling time (43.3 vs. 44.5) despite the identical experimental conditions, hence a better quality 
of cells in the 3D populations. In other words, the lower the population doubling time, the lower 
the % specific apoptosis, the slower the cells proliferate, the more guarded they are against DNA 
damage, the less the % apoptotic capacity. This proves our hypotheses that both hypercapnia and 
a 3D culture system combined are more effective in producing greater cell numbers in the same 
amount of time in contrast to hypercapnia alone in a traditional 2D culture system.  
Conclusions 
Researchers in the stem cell culturing field have broadly overlooked carbon dioxide and focused 
more on the effect of oxygen. Almost all cell proliferation systems in the literature include the 
culturing of stem cells at 5% carbon dioxide. Despite human blood containing an analogous 5% 
dissolved carbon dioxide, stem cells in the bone marrow exist in a microenvironment with a 
higher carbon dioxide concentration. This thesis aimed at analysing and investigating the effects 
of hypo- and hypercapnia on the proliferation of hematopoietic progenitor stem cells (KG-1a cell 
line). In addition, these cells’ apoptotic capacity, morphology, surface antigen integrity, and 
metabolism were also examined under varying carbon dioxide conditions. This work also 
highlighted the significance of culturing stem cells in 3D bioreactor vessels compared to 2D 
ones. Once again, the 3D system is higher in similarity to the actual in vivo microenvironment of 
these cells. 
This work analysed the effects of hypo- and hypercapnia using the cell line KG-1a to model real 
human hematopoietic stem cells. This is a reasonable assumption to make, given that both KG-1a 
and human hematopoietic stem cells express the CD34
+
 antigen and have other analogous 
properties (detailed in Section 3.1). This work was successful in proving that in both 2D and 3D 
culture systems, hypercapnia (15% carbon dioxide in air) decelerates proliferation rate but 
increases overall expansion of hematopoietic progenitor stem cells (KG-1a) without disturbing 
cell surface integrity in comparison to hypocapnic (0.5-1% carbon dioxide in air) and control 
(5% carbon dioxide in air) populations. Also, we established that the apoptotic capacity of these 
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KG-1a cells is delayed under the effect of hypercapnia in both 2D and 3D culture systems. And 
finally, this work has demonstrated that KG-1a cells can successfully proliferate within a 3D 
culture system (bioreactor) to yield comparable cell concentrations to traditional 2D systems 
(culture flasks).  
Since human stem cells are difficult to obtain with respect to strict ethics and policies governing 
their availability and use, growing and culturing stem cells in scalable quantities is therefore a 
huge advantage for both research and therapy. This study has succeeded in adding to the current 
body of knowledge that exists on hematopoietic stem cell expansion and it may potentially 
provide the foundation to enhancing proliferation systems of hematopoietic stem cells and 
therefore contribute to resolving numerous diseases. 
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1. Chapter 1: An Introduction 
to Stem Cells 
1.1 Background 
The human body is an intricate system compiled of hundreds of cell types, all organized into 
specialized tissues, that constitute specific organs which are crucial for regular functioning of the 
body. Stem cells are a distinctive class of cells in that they are unspecialized, can self-renew, 
(10) and can differentiate to give rise to any foetal or adult cell type (muscle cells, nerve cells, fat 
cells and skin cells) (Figure 1.1).  
 
Figure  1.1: Embryonic Stem Cell Differentiation into multiple cell lineages (11).  
ESC: embryonic stem cell 
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Embryonic stem cells (ESCs) are extracted from the inner cell mass of the developing 
mammalian blastocyst (Figure 1.2) (12, 13). These cells are also characterized by their infinite 
capability to self-renew while maintaining their aptitude to differentiate into all three primary 
germ layer cell lineages (Figure 1.3) (7, 12).  
 
Figure  1.2: Development of the blastocyst from the zygote; PB: Polar Bodies (14). 
A stem cell’s proliferative capability begins to decrease as it commits to a specific lineage 
through its development; at this stage, it is identified as a progenitor cell (7). These progenitor 
stem cells, also known as adult stem cells or tissue-specific cells, are multipotent and have a 
lower proliferative capability in contrast to premature stem cells; nevertheless, they are still 
capable of dividing into multiple cell types (7). For example, hematopoietic stem cells (HSCs) 
are the progenitor stem cells of all blood cells and many cells of the adult immune system (15). 
 
Figure  1.3: Stem Cell Division and Pluripotency. Stem cells are pluripotent and can divide or 
differentiate into progenitor cells which are multipotent. The latter can also divide or 
differentiate into cells of the same tissue. Differentiated cells can divide but are incapable of 
differentiating into other cell types (16). 
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Stem cells distinctively divide asymmetrically, i.e. the parent cell divides to produce two 
daughter cells with separate fates: a new stem cell and a progenitor cell destined for terminal 
differentiation (17). Asymmetric differentiation maintains homeostasis within regenerative tissue 
such as the bone marrow (BM), in other words, it ensures a balanced number of stem cells is kept 
while differentiated progenitor stem cells are produced in parallel to meet the requirements of 
regular cell turnover (17).  
Stem cells have more recently attracted interest in scientific research and their use is increasingly 
developing in many therapeutic fields and applications (6, 7). The latter include cell 
transplantation therapy (8), cardiac cell therapy (6), genetic manipulation studies (7), tissue 
differentiation/regeneration (9), and many more.  
1.2 Ethics, Policies and Limitations 
The employment of ESC, especially from human sources, in scientific research is currently an 
elevated topic in ethical and political guidelines in many countries (18). On one hand, human 
ESCs demonstrate great potential benefits in the research and treatment of disease; however, 
their exploitation remains controversial since they are initially obtained from embryos of aborted 
foetuses (18, 19). In Australia, using human ESCs in reproductive cloning is prohibited as stated 
by the Prohibition of Human Cloning Act 2002 (19). Nevertheless, The Research Involving 
Human Embryos Act 2002, which came into effect in June 2007, allows the use of excess human 
ESCs for research purposes only, given that the researcher/supervisor has obtained a license from 
the National Health and Medical Research Council Licensing committee (19).   
Since human stem cells are difficult to obtain with respect to strict ethics and policies governing 
their availability and use, growing and culturing stem cells in scalable quantities is therefore a 
huge advantage for both research and therapy. This leads to the broad aim of this work which is 
to discover means of enhancing stem cell proliferation. 
1.3 Hematopoietic Stem Cells and Hematopoiesis 
BM is the flexible, spongy tissue found within large bones in the hollow spaces (Figure 1.4). 
This material is rich in blood vessels and fibres that generate white blood cells (WBCs), red 
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blood cells (RBCs), and platelets (20). WBCs are the principal components of the immune 
system, RBCs are responsible for the transport of carbon dioxide (CO2) and oxygen (O2) to and 
from the lungs to all the body’s cells, while platelets aid in preventing bleeding (20).  
BM was suggested the dominant site for early hematopoiesis in adult humans over a century ago 
(21) and HSCs are the cells accountable for blood renewal. These cells are primarily found 
within the BM at very low concentrations (0.01-0.05%) and in the peripheral blood (PB) at even 
lower concentrations (0.001%) (22). Nonetheless, the turnover of cells in the hematopoietic 
system in a man weighing 70kg is close to 10
12
 cells/day (23). 
The HSC is possibly the most thoroughly investigated and characterised somatic stem cell and 
the most commonly used in research and therapeutical practices. Even so, in vitro HSC-
expansion remains somewhat a challenge which hinders their therapeutic potential.  
 
Figure  1.4: Diagram of the anatomy of the bone (24). 
It was only a few decades ago that the concept of “niches” was proposed for HSCs within the 
complex three-dimensional BM structure (25). A niche is a specialized anatomical site, or 
microenvironment, fundamental for maintaining normal stem cell functions (self-renewal, 
differentiation, quiescence, and migration) (26). BM niches produce signals and cell adhesion 
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molecules that together give rise to the HSC-niche synapse (17). These signals regulate HSC 
dormancy, proliferation, and differentiation (17). At least two HSC BM niches have been 
described: endosteal niche (supports steady-state hematopoiesis and maintains HSC quiescence) 
and perivascular niche (allows self-renewing HSCs to access the vasculature) (27-29). Each 
niche provides a specialised microenvironment in which the HSCs’ pluripotency is maintained 
(cells self-renew) but differentiation is inhibited (17).  
Table  1.1: Cytokines utilised in HSC culture ex vivo (22). 
Cytokine  Function Reference 
 Flt-3L, FL Survival of HSCs (30, 31) 
 G-CSF Mobilization of HSCs to PB (32) 
 IL-3 Proliferation of HSCs (with IL-6) (33) 
 IL-6 Proliferation of HSCs (with IL-3) (34) 
 IL-10 Proliferation of HSCs (35) 
 IL-11 Shortens the G0 period of the cell cycle of HSCs (36) 
Jagged-1 HSC self-renewal (37) 
PDGF Mitogen for connective tissue cells (31) 
Stem cell factor  Growth factor for HSC progenitor cells (33) 
Thrombopoietin  Stimulator of megakaryocytopoiesis (31, 36) 
CSF: colony-stimulating factor; IL: interleukin; PDGF: platelet-derived growth factor. 
Hematopoiesis within these niches is relatively complex and involves several molecular and 
cellular interactions. HSCs secrete glycoproteins, also known as cytokines, which induce/inhibit 
stem cell differentiation, apoptosis, and expansion depending on the concentrations in which they 
are present. It is possible to supplement cell cultures with cytokines to provide essential physical 
and physiological support and increase cell culture quality. Table 1.1 above summarizes a few 
examples of cytokines used in the ex vivo culturing of HSCs. 
HSCs are also characterized by specific surface markers. Identifying and separating HSCs is 
solely dependent on precise surface markers which are summarized in Table 1.2 Since these 
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markers are not however entirely exclusive to HSCs, and in order to avoid yielding 
heterogeneous populations during any selection, combinations of positive and negative markers 
are used instead (22). 
Despite the mass literature present on HSCs, nevertheless, current literature still falls short of 
accurately describing the composition of the HSC BM microenvironment, especially in terms of 
CO2 gas distribution. Yet, in order to successfully develop rational methods for the expansion of 
HSCs, an understanding of this microenvironment is crucial alongside other factors discussed 
above (cytokines, surface markers, and others). This thesis will pursue to comprehend the 
significance of CO2 in the HSC early life cycle and also the role of CO2 in the BM on HSC 
proliferation/expansion, apoptosis, morphology, metabolism, and CD34
+
 integrity. This initiative 
is novel and has not been attempted before in the literature since CO2 has been almost 
completely overlooked in this regards.  
Table  1.2: Summary of human HSC markers (22). 
Surface Marker Function 
CD34
+ or - 
Cell–cell adhesion 
Thy 1
-
 (CD90) Cell–cell interaction 
CD38
- Synthesizes cyclic ADP-ribose; indicates differentiation to both erythroid and 
myeloid progenitors 
c-Kit
-
 (CD117) Tyrosine kinase receptor for stem cell factor (SCF) 
AC133
-
 (CD133) Unknown function 
lin
-
 (lineage) Generic designation for several markers of blood cell lineages 
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1.4 Case Study: Hematopoietic Stem Cells and Leukaemia  
 
Figure  1.5: Illustrative examples of blood samples from a healthy person versus leukaemia 
patient (24). 
HSCs are, at present, one of the main stem cell classes used clinically. They are used for the 
treatment of immunodeficiency and hematopoietic-related disorders, such as leukaemia (15, 38). 
Leukaemia is often described as a ‘liquid cancer’. This means the disease develops from cells 
within the BM, the bloodstream, and/or the lymphatic system (39, 40). Immature WBCs 
proliferate uncontrollably inside the body of a leukaemia patient and out crowd the BM and enter 
the bloodstream and lymph system (Figure 1.5) (39, 41). These abnormal WBCs do not carry out 
the tasks of normal WBCs, they grow faster than all other cells, and they do not die when they 
should (i.e. irregular apoptosis) (39, 40). A person with leukaemia may develop several adverse 
affects, some of which include infection, anaemia, bleeding, bruising, decreased levels of 
immunity, and in severe cases death (40, 41). 
In the mid 1860s, arsenicals were first utilised for the treatment of leukaemia up until the 1940s 
when work begun on the development of folate and its antagonists. Between these two periods, 
no progress was made for acute leukaemia and only little expectation for cure was given to 
patients. Over the past 20 years, and despite the fact that no significant new chemotherapy agents 
have been introduced, 75-80% overall cure rates are now reported (42). The biotechnology 
revolution between the ‘70s and the ‘90s opened many doors for bone marrow transplantation 
(BMT) practitioners in health care by the end of the 20
th
 century (Table 1.3).  
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Table  1.3: Timeline of events for BMT (43). 
Year Event 
1892 
Marrow is given as an extract for the treatment of anaemia and 
tuberculosis 
1900 Successful red blood cell transfusion 
1930 Discovery of human blood groups 
1940 Intravenous-administration of BM 
1945-1965 ABO blood grouping, understanding of B and T cells and antigens 
1950 Successful cryopreservation of BM 
1959 First reports of BMT for solid tumours  
1965 Importance of HLA discovered 
1968 First reports of BMT in children 
1980 
Advances in marrow purging, GVHD management, peripheral stem 
cell harvesting 
1990s 
Better understanding of HLA matching, peripheral stem cell 
transplants 
HLA: human leukocyte antigen; GVHD: graft versus host disease 
The use of blood and BM HSC for treatment of disease dates back to the early 1920s; thus, 
progress in research over the years has led to the innovation of clinical blood and BMT (44). 
BMT is an imperative therapy for thousands of people who would otherwise die of their disease, 
and leukaemia patients are very often directed towards this option (43). It can be split into three 
categories based on the nature of the donor which can be the patient him/herself, an identical 
twin, or another person (autologous, sygeneic, and allogeneic, respectively). The most critical 
problem today in curing leukaemia is the enormous shortage in the number of donors. Only 30-
40% of patients have an HLA-matched sibling/parent/relative, and the odds of acquiring HLA-
compatible marrow from an unrelated donor are no doubt very slim (20). 
Therefore, the aim of this project was to work towards resolving the major obstacle that 
leukaemia patient still face and that is the difficulty in obtaining a healthy and well-matched BM 
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sample for transplantation after chemotherapy and/or radiation. The proposed idea is to find 
ways to expand an initial small number of the patient’s very own healthy cells into maximum 
numbers, in minimum time for autologous transplantation. 
To do so, we must start off by better understanding the HSC-niche microenvironments and 
discover successful methods of expansion that will meet therapeutic requirements. This is the 
broad aim of this thesis where hematopoietic progenitor stem cells are being cultured under 
varying CO2 conditions and in 3D bioreactor environments  in aim of mimicking their actual in 
vivo microenvironments and maximizing their proliferation. This also demands continuous 
evolution of bioreactor technology for efficient and rapid expansion of cell lines utilising the 
patient’s own cells as starter cultures. We have chosen to focus on CO2 since it has been 
somewhat disregarded throughout the literature and we firmly believe that this gas plays an 
integral role in the HSC niche. The next section will provide the reader with an introduction to 
CO2 in mammalian cell systems and the gas’ role in the apoptotic cascade, while the influence of 
varying CO2 concentrations on the proliferation of these cells in the literature will be presented 
in Sections 2.1 and 2.2.  The background to bioreactor technology and its associated operational 
parameters in stem cell culturing are reviewed and discussed in Sections 2.4 and 2.5.  
1.5 The Role of Carbon Dioxide in Cell Culture and in Apoptosis  
In mammalian cells, CO2 is essential for the synthesis of pyrimidines, purines, and fatty acids 
(45). It is also the end product of aerobic metabolism in cells from which it then diffuses into the 
tissue spaces and then into the capillaries. All living cells hence require CO2 for proliferation. If 
the partial pressure of CO2 (Pco2) increases over a certain limit, the metabolic activity of cells 
will be suppressed. Numerous suggestions have been put forward to explain this proliferation 
inhibitory effect of CO2: (a) CO2 initiates a decrease in the intracellular pH, (b) enzymatically 
catalysed reactions and enzyme synthesis are inhibited or stimulated, (c) the effect that CO2 may 
have on the cell membrane may indirectly affect proliferation inhibition (46). Nevertheless, it is 
most likely that two major factors are involved in this phenomenon: (i) the modification of the 
cell membrane and/or the function of membrane proteins due to both aqueous CO2 and HCO3
-
, 
and (ii) alteration of cytoplasmic enzyme behaviour (46).  
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The precise role of CO2 in cellular niches is intricate because it can exist in many forms [CO2, 
bicarbonate (HCO3
-
), carbonic acid (H2CO3), or carbonate (CO3
2-
)] and can be regarded as both a 
nutrient and a potentially inhibitory byproduct. Because CO2 is a non-polar molecule, it can 
easily diffuse across cellular membranes and reduce intracellular pH. It has thus been shown that 
elevated Pco2 levels  are detrimental to mammalian cells and can inhibit many key processes, 
such as proliferation, nutrient utilization, recombinant protein production, and protein 
glycosylation (47-55) . Hence, both build-up and excessive removal are unfavourable (56). 
Humidified cell incubators are typically controlled at 5% CO2 levels in air. This concentration of 
CO2 ensures that the buffer within the cell medium works as intended to maintain a somewhat 
neutral pH. This is a close mimic of the actual in vivo system; our blood contains dissolved CO2 
at a concentration close to 5%, the majority in the form of HCO3
-
 which acts as a pH buffer to 
permit gas, nutrient and metabolite fluctuations without causing significant pH variations. 
However, the concentration of 5% dissolved CO2 in cell cultures will alter accordingly based on 
the cellular release of CO2, lactate, and other byproducts during proliferation/metabolism. The 
result is excess CO2 forced into or out of the atmosphere to maintain a balance between the two 
systems via what is known as Henry’s Law. 
Henry’s law (Equation 1) states that “at a constant temperature, the amount of a given gas that 
dissolves in a given type and volume of liquid is directly proportional to the partial pressure of 
that gas in equilibrium with that liquid”; in other words, the solubility of a gas in a liquid is 
directly proportional to the partial pressure of that gas above the liquid. 
p = KH c  Equation 1: Henry’s Law 
Where p is partial pressure of the solute in the gas above the liquid, c is concentration of the 
solute, and KH is Henry’s law gas constant. KH for CO2 = 29.41 L.atm/mol.  
In closed static cell culture systems, the cells proliferate and simultaneously produce CO2 which 
builds up in the headspace. According to Henry’s law, this prevents the gas from diffusing out of 
the medium, resulting in poorly dissociated HCO3
-
 which generates an excess of hydrogen ions, 
in turn, decreasing overall pH. The solution to this is a very large headspace (at least tenfold 
greater than the medium volume) which is easily achievable in small scale cultures, but becomes 
near impossible as experiments are scaled up. Another solution is a system with continuous air 
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flow in and out of the culture vessel via filters which is not very effective for static 2D flasks. 
The more practical solution is for the cells to be cultured in stirred suspension in 3D bioreactors 
with continuous flow of air in and out of the vessel, accompanied by monitoring and control of 
dissolved gas concentrations within the cell medium.  
The stem cell niche (O2/CO2 tension, pH, temperature...) directly manipulates stem cell 
proliferation, differentiation, and apoptotic capacity (57). Apoptosis was first described over 40 
years ago as genetically programmed cell death. When a mammalian cell undergoes necrosis, it 
dies inadvertently due to injury and deteriorates uncontrollably by swelling and bursting coupled 
with the initiation of an inflammatory response in the surrounding tissue (58). Unlike necrosis, 
apoptosis is induced by specific signals (e.g. heat shocks, drugs, infection, toxins) activating the 
cell’s genetic control machinery via cell surface death receptors (58). This is then followed by a 
cascade of intracellular responses which remain only partially understood: signal transduction  
transcription factor activation  stimulation of apoptosis-associated genes (58). The process 
then terminates in cell destruction and DNA degradation.   
The mitochondrial membrane permeability is deemed accountable for the activation of the 
apoptosis cascade; the stability of this membrane prevents it (59). In cell cultures, elevated CO2 
concentrations (i.e. higher than 5% in air) acidify cell medium, and acidic pH values stabilise the 
mitochondrial membrane (59, 60); hence, it can be hypothesised that increased CO2 levels may 
deter apoptosis in this way. Moreover, reactive oxygen species (ROS) are reported to be the main 
stimulants of apoptosis (61). Increased levels of CO2 decrease cellular consumption of O2 which 
consequently reduces ROS production independently of medium pH (59, 62), once again 
delaying apoptosis (59).  
Therefore, CO2 can be regarded as both an essential gas and toxin to stem cells. Wider 
investigations need to be undertaken in this field in order to acquire a clearer picture of the level 
of the necessity/toxicity of CO2 to stem cells, especially within the BM. Throughout this project, 
the extent of the influence of CO2, both hypo- and hypercapnia (decreased and increased levels 
of CO2, respectively), on hematopoietic progenitor stem cell apoptosis was explored. It was 
hypothesised that hypercapnia delays apoptosis while hypocapnia accelerates it. 
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1.6 Hypotheses and Objectives 
In Summary, this dissertation explores the following hypotheses: 
i. Hypercapnia decelerates proliferation rate but increases overall expansion of 
hematopoietic progenitor stem cells (KG-1a) without disturbing cell surface integrity. 
ii. Apoptosis of KG-1a cells is delayed under the effect of hypercapnia in both 2D and 3D 
culture systems. 
iii. KG-1a cells can successfully proliferate within a 3D culture system (bioreactor) to yield 
higher cell concentrations than 2D systems. 
To examine the above hypotheses, the following steps were undertaken:  
i. Assess the proliferation, morphology, apoptotic capacity of KG-1a cells in 2D culture 
systems. 
ii. Research, design, and manufacture of a suitable bioreactor to carry out 3D studies in. 
iii. Set up 3D culture system comprised of : online monitoring and control circuit and 
feeding circuit 
iv. Assess the proliferation, morphology, apoptotic capacity, cell surface antigen integrity, 
pH, and metabolism of KG-1a cells in 3D culture system. 
1.7 Thesis Outline 
This dissertation presents 6 chapters. Chapter 1 will introduce the reader to stem cells and their 
current use in research/therapy with specific focus on hematopoietic stem cells and their role 
towards the treatment of leukaemia. This chapter will also emphasise the importance of carbon 
dioxide in mammalian cell culture, particularly in the apoptosis cascade. Chapter 2 will review 
the role of carbon dioxide in the hematopoietic stem cell microenvironment and the expansion of 
mammalian stem cells in hypo- and/or hypercapnic conditions. It will also review in detail 
conventional 2D culture methods versus 3D bioreactor culture systems and related 
configurations and parameters, with specific concentration on various bioreactor systems used in 
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the literature for the expansion of hematopoietic stem cells. Chapter 3 will discuss experimental 
materials and methods in detail. The experimental work conducted will be portrayed and results 
discussed in Chapters 4 and 5, respectively, then in Chapter 6 relevant conclusions and future 
recommendations will be made. This thesis will also provide a concise literature review on the 
culturing of hematopoietic stem cells in model-based controlled 3D culture systems. Since this 
review is slightly beyond the main scope of our work, it will be presented at the end of the 
dissertation for the reader’s expediency. The purpose of the latter review is to provide the reader 
with an indication of where the literature currently stands with respect to the expansion of 
hematopoietic stem cells in controlled 3D systems, which will, in turn, give insight into the 
future potential(s) of our own work presented herein. 
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2. Chapter 2: Literature 
Review 
Culturing stem cells is a complex challenge with regards to establishing an in vitro environment 
near-identical to that of the in vivo one of the cells of interest in terms of culture parameters. The 
body has several types of cells, all growing in varying conditions in terms of gas distribution, 
nutrients, blood flow, growth surface(s), pH, and temperature. For instance, HSCs/RBCs are 
found in both the blood and the BM; nevertheless, the microenvironment differs greatly between 
the two sites. Human blood has a maintained dissolved CO2 concentration close to 5% (40 
mmHg), which is very different from the environment surrounding blood progenitor stem cells 
(HSCs) in vivo within BM niches (3, 4). In order for stem cells to be considered for successful 
therapeutic use, the in vitro expansion of these cells must be satisfactory, and this will require 3D 
mimicking of the stem cell-niche microenvironments.  
Of these numerous physio- and biochemical parameters which manipulate and/or regulate cell 
proliferation, dissolved O2 (DO) is regarded the most significant of the cellular 
microenvironment (63-65) and is thus the most examined throughout. The literature broadly 
agrees that since a hypoxic microenvironment is maintained within human BM with O2 tension 
lying between 1 and 6%, hypoxic conditions (O2 concentrations of approximately 2-5%) are thus 
optimal in order to maintain cell pluripotency, whereas atmospheric O2 levels (approximately 
20%) enhance proliferation and division (66).  
Besides O2, dissolved CO2 in mammalian cells is equally significant, but has been rather 
disregarded throughout the literature. Humidified cell incubators are generally maintained at 5% 
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CO2 in air in the vast majority of HSC-related proliferation studies. Evidence to provide 
justification for selecting this specific concentration of CO2 in hematopoietic progenitor cell 
proliferation studies is lacking. The literature does not currently define the precise distribution of 
CO2 within BM niches, it is however established that the 5% used for typical cell proliferation is 
lower than that actually encircling BM HSCs in human tissue (3, 5).  
2.1 The role of CO2 in the HSC 3D Microenvironment 
Each cell class exists within a unique environment which provides the cell with optimal 
conditions for optimal cell proliferation and expansion, thus all cells respond and behave 
differently to different surroundings. Therefore, in order to successfully optimise the expansion 
of HSCs for these reasons discussed, it is first essential to comprehend the actual in vivo 
environment of these cells. The design of this defined cell expansion protocol must take into 
account several parameters, such as media composition, sheer stress, pressure, temperature, and 
dissolved gas composition. Herein, this review will be specifically focusing on the role of CO2 in 
the HSC-microenvironment.  
As suggested over a century ago, the BM is the chief site of hematopoiesis in human adults (21); 
however, more recently, it was suggested that the BM itself is a more complex 3D structure 
comprising of subordinate sections known as “niches” (25). These niches are distinct 
subdivisions that are crucial for the maintenance of normal HSC-operations, such as self-
renewal, differentiation, quiescence, and migration (26). Two examples of niches identified 
within the BM include: (i) the endosteal niche, which maintains hematopoiesis and quiescence, 
and (ii) the perivascular niche, which permits HSC-migration to the vasculature (27-29). 
The vast majority of HSC-related studies report culturing these cells in 5% CO2 concentrations in 
air. This particular concentration of CO2 sustains the media by maintaining the buffer within a 
rather neutral pH range. Nevertheless, limited verification exists to justify this CO2 concentration 
for culturing BM progenitor cells. Physiologically dissolved CO2 is typically equivalent to a Pco2 
of 50-70 mmHg (5% dissolved) in human blood at 37
o
C, but this value differs significantly to 
that of HSC-niches within the BM. Current literature only vaguely describes CO2 distribution in 
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the BM niches, it is however well established that the 5% CO2 depended in standard cell 
expansion studies is lower than that surrounding blood progenitor stem cells in BM niches (3, 5).  
In summary, cell proliferation is dependent upon numerous factors, more critically O2 and CO2. 
Varying these parameters generates variations within the overall cellular system. These 
variations can then be consequently used to optimise cell proliferation in vitro (63-65). Ideal 
values of CO2 are essential in order to minimize process and inconsistency and maximize 
efficiency. This strategy must consist of precise monitoring and accurate control of the overall 
system to achieve process standardization.  
2.2 The Expansion of Mammalian Stem Cells in Hypo- or Hypercapnic 
Conditions 
The literature has witnessed the optimization of stem cell expansion in terms of suitable DO 
concentrations on a much wider scale than that of dissolved CO2. A hypoxic environment is 
maintained within the BM where DO concentrations lie between 1 and 6% (2, 3). Generally, 
hypoxic environments (DO concentrations of 2-5%) have been shown to retain stem cell 
pluripotency, while normoxic conditions (DO concentration of about 20%) encourage mature 
cell proliferation and proliferation (66). Cell cultivation in normoxic/hyperoxic conditions would 
hence prompt cells to differentiate, i.e. to lose pluripotency, and cell viability would decrease 
simultaneously due to oxidative stress (63). Hence, decreased O2 levels are favoured not only for 
the maintenance of cell integrity, but also because this is a closer mimic of the almost anaerobic 
in vivo environment surrounding BM progenitor cells. 
Carbon dioxide is itself a toxic gas and has been shown in the literature to have inhibitory effects 
on cell cultures. At higher concentrations of dissolved CO2, combined with higher partial 
pressures, and lower temperatures, CO2 equilibrium is shifted towards the aqueous phase (67). 
As mentioned, pH within cell culture medium is directly related to the concentrations of 
dissolved CO2 and lactate. Both CO2 and lactate, which are produced via cellular respiration, are 
present in equilibrium with water in the form of carbonic and lactic acids. Elevated pH (greater 
than 7.0-7.4) levels were found to induce megakaryocytic and erythroid differentiation. On the 
other hand, decreased pH levels have been illustrated to favour granulocyte proliferation and 
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differentiation (68, 69). Parolini et al. revealed that pH levels lower than 6.4 cause a sharp 
decrease in cell survival (70).  
Dissolved CO2 in mammalian cells is crucial for steady cell proliferation. It is essential for 
pyrimidine, purine, and fatty acid synthesis (45). CO2 is also the end product of cellular aerobic 
metabolism from which it then diffuses into the tissue and finally into the capillaries. However, 
the exact purpose that intracellular CO2 serves is much more complex since it can exist in several 
forms: CO2, HCO3
-
, H2CO3, or CO3
2-
; it can either be considered a nutrient, or a potentially 
inhibitory byproduct. Elevated Pco2 levels can hinder key cellular performances, such as 
proliferation and expansion, nutrient consumption, recombinant protein production, and protein 
glycosylation (47-55). The inhibition of cell proliferation due to excessive CO2 has been 
hypothesized to be a result of: (a) a decrease in intracellular pH, (b) inhibition or stimulation of 
enzymatically catalysed reactions, or (c) modification(s) in the cell membrane and/or in 
membrane proteins via CO2 and HCO3
-
 (46). It can thus be concluded that both the build-up as 
well as excessive removal of intracellular CO2 are unfavourable (56). 
ROS are the main stimulators of apoptosis and are suppressed by elevated levels of CO2 (61). In 
other words, an increase in Pco2 will bring about apoptosis inhibition. The mitochondria play a 
major role in this cascade of events (59, 71); changes in the mitochondrial membrane 
permeability could potentially trigger apoptosis, while the stabilization of the latter could hinder 
it (59). Cell medium has been shown to acidify in excessive CO2 (59), simultaneously, the 
mitochondrial membrane has been shown to stabilize in acidic conditions (60), hence it can be 
speculated that elevated CO2 levels slow down apoptosis in this way. The literature has 
demonstrated that CO2 acts as a weak acid to maintain intracellular pH at relatively low levels. 
CO2 diffuses across the cell membrane, combines with intracellular water to create carbonic acid, 
which then dissociates into HCO3
-
 and hydrogen ion and consequently regulates the intracellular 
pH (59, 72-74). 
The affinity between O2 and haemoglobin is significantly influenced by CO2, consequently 
manipulating the oxyhemoglobin dissociation curve (75). Increases in Pco2 bring about a right-
hand shift of the curve and vice versa. The latter is known as the Bohr effect and is principally 
the outcome of subsequent pH alterations (75). So, increases in Pco2 lead to a decrease in the 
affinity between O2 and haemoglobin and a decrease in pH.  
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Throughout the literature, humidified cell incubators are typically controlled at 5% CO2 levels in 
air in the vast majority of cell-culture studies. This concentration of CO2 ensures that the buffer 
within the medium works as intended to maintain a somewhat neutral pH. This is also a close 
mimic of the actual in vivo system, where human blood contains dissolved CO2 at a 
concentration close to 5% (40 mmHg), but is very different from the environment surrounding 
progenitor stem cells such as HSCs in vivo within BM niches (3, 4). Very little evidence is 
present to provide a rationale for choosing this concentration of CO2 for culturing progenitor 
cells of the BM. Oxygen concentration, on the other hand, has been researched much more than 
CO2 to optimise in vitro culture conditions of BM progenitor cells. It is now well known that a 
hypoxic environment is maintained within the BM where O2 tension ranges from 1 to 6% (2, 3). 
Despite current literature not accurately defining the distribution of CO2 in the BM niches, it is 
however well established that the CO2 concentration (5%) used in standard cell culturing 
practices is lower than that surrounding the BM-HSCs in the tissues (3, 5).  
From Table 2.1, it is evident that a wide gap exists in the literature with respect to the 
proliferation of cells in hypo-/hypercapnic conditions, and an even wider gap in terms of HSC 
proliferation in such conditions. This area has only been narrowly investigated with only very 
few findings reported. It also appears that conflicting evidence is present amongst these articles, 
where few suggested the advantages of hypercapnia and others the disadvantages, similarly in 
terms of hypocapnia.  
Table  2.1: Summary of the literature on hypo/hypercapnia with respect to mammalian cells. 
CO2  Result 
Reference/ 
Year 
Agrees/Disagrees 
with thesis 
hypothesis 
30% CO2  
Lowered pH (6.0-6.4) 
Erythropoiesis stimulation 
(76) 
1967 
Agrees 
10% CO2  
Enhanced hamster embryo 
development 
(73) 
1987 
Agrees  
35 mmHg pCO2 Maximum productivity (77) Agrees 
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79% viability 1996 
103 mmHg pCO2  
Productivity reduction 
72% viability 
Agrees 
148 mmHg pCO2  
CHO cell proliferation inhibition 
58% viability 
Disagrees 
70 mmHg pCO2  
Regulated excitatory synaptic 
interactions of brainstem neurons 
(78) 
2008 
n/a 
6% CO2 in 3% O2 
Prevents cell damage and 
preserves a high number of 
functional HSCs and progenitors 
(59) 
2009 
Agrees 
120 mmHg pCO2  
Inhibited epithelial cell 
proliferation 
(79, 80) 
2009/2011 
Disagrees 
CO2-Free 
17.25 ± 3.65-fold expansion was 
attained in human HSCs from 
umbilical CB 
(81) 
2011 
Disagrees 
120 mmHg pCO2 Inhibited fibroblast proliferation 
(80) 
2011 
Disagrees 
Atmospheric CO2 – 
(0.04%) 
Reduced cell density of MSCs 
compared with standard 5% CO2 
cultures 
(57) 
Agrees 
1.5% CO2 
Enhanced expression of 
pluripotency and differentiation 
genes in mouse ESCs 
(82) 
2014 
Disagrees 
0.05% CO2 in 20% O2 
Stem cell activity significantly 
decreased (83) 
2014 
Agrees 
9% CO2 in 5% O2 
Stem cell activity maintained 
Survival of CD34
+
 cells doubled 
Agrees 
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Survival of CFCs cells doubled 
Decreased apoptosis 
CHO: Chinese hamster ovary; CB: cord blood; CFC: colony-forming cell 
In this concise review, we have illustrated where the literature currently stands with respect to 
cell proliferation in varying CO2 environments. The latter has been very thoroughly investigated 
in terms of O2, but for some reason, CO2 has been dismissed, despite being a crucial factor for 
cell proliferation and expansion. In future work, we expect to see more studies focusing on this 
topic with the aim of improving cell (specifically HSC) proliferation so as to mimic their actual 
in vivo environment. 
2.3 Three Dimensional Culture Systems – Bioreactors 
Successful stem cell engineering greatly depends on appropriate cell cultivation techniques, the 
essence of which is 3D culture systems, or bioreactors. Bioreactor design, management, and 
process have been well established over the years in engineering fields, but they are rather 
innovative in biotechnology and medicine. The term ‘bioreactor’ generally refers to a closed 
culture system that permits the control and monitoring of physiochemical and biochemical 
parameters that influence biological systems (84). In line with the requirement of diverse 
cell/tissue types, bioreactor engineering has witnessed the development of more detailed and 
intricate systems that meet the needs of the specific cell type and/or mimic the cell type’s distinct 
organ to enhance proliferation. Specifications and designs of the varying bioreactor types have 
been illustrated in the literature in great detail (63). Bioreactors are used extensively for the 
production of many practical products such as pharmaceuticals, various DNA vaccines (85), 
monoclonal antibodies (86), Insulin (87), antibiotics (88), ethanol (89), and citric acid (90). This 
is most commonly achieved via the use of biological agents, including microorganisms (bacteria, 
fungi, yeast), enzymes, plant and mammalian cells (91).  
A great deal of cell-based work in the literature encompasses cell proliferation on flat two 
dimensional surfaces (e.g. T-flasks, well plates, blood bags), where the cells adhere and grow in 
cell clusters known as embryoid bodies (EB) in static conditions (12, 63). These methods are 
straightforward, simple to handle, and of low economical costs. Their drawbacks however are 
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that gas exchange is only permissible at the medium surface, and concentration gradients are 
very likely to occur in the medium itself (63). Therefore, it is almost impossible to control 
parameters such as O2 levels and pH (63). Three dimensional apparatus hence allow for an 
increased surface area for the cells to grow in and more strongly resemble the in vivo 
environment of cells (Table 2.2) (63).  
Table  2.2: Comparison between stationary and stirred cell culture methods (92). 
Parameter(s) Static Culture Dynamic Culture 
Nutrient 
availability 
Concentration gradients exist Homogenous distribution 
O2  
No control; gas exchange mainly 
occurs at medium surface 
Homogenous distribution via 
sparging and agitation 
pH 
No online monitoring system; pH 
gradients exist 
Online monitoring possible; uniform 
pH throughout medium 
Sampling 
Must handle the culture; 
contamination  
Sampling of the media possible 
without handling the culture directly; 
decreased contamination 
Handling 
Culture must be handled during cell 
passage 
Handling only occurs during 
inoculation and harvesting 
 
Stem cell culturing in 3D agitated bioreactors is overall advantageous over standard methods of 
static two-dimensional (2D) culturing and have several key advantages. These include achievable 
high cell densities, ease of scale-up and control, homogeneity, particularly with respect to O2 
distribution, and other benefits (93). Through the stirred suspension technique, the cells are 
exposed to elevated and enhanced amounts of nutrients and gases. Moreover, the various 
physiochemical (pH, temperature, osmolarity, DO, shear stress) and biochemical (nutrients, 
metabolic waste products, growth factors, cytokines) parameters can also be controlled much 
more easily and analysed for improved results (Table 2.3) (63, 65). 
 28 
 
Table  2.3: Critical parameters that manipulate stem cell expansion and/or differentiation in 
bioreactors (63). 
Variable Category Examples of critical parameters 
Physiochemical 
• pH values  
• Temperature 
• Osmolarity (measurement of the osmotic pressure of a given 
growth medium) (94) 
• DO tension  
• Hydrodynamic shear stress  
Biochemical 
• Nutrients  
• Metabolic byproducts (lactate and ammonia) 
• Growth factors and Cytokines   
 
A study by Cameron et al. which investigated the development of human ESC-derived EBs 
reported a 15-fold increase in the total number of EB-derived cells in a stirred suspension culture 
in contrast to just a 4-fold increase in stationary 2D cultures (65). King and Miller (93) reported 
expansion of mouse neural stem cells for 44 days in stirred bioreactors, and more recently Amit 
et al. (95) described a system supporting a suspension culture of human pluripotent stem cells 
where they reported stable karyotype and pluripotency even after 20 passages, and increases in 
cell numbers by 25-fold in just ten days (95). 
One of these more advanced bioprocesses is culturing ESCs in three-dimensional (3D) stirred 
suspension culture, i.e. a medium-perfused bioreactor system. Stirred suspension bioreactors are 
capable of producing high quantities of desired mammalian cells, and when coupled with 
computerised online monitoring and control, the operator has increased control over several 
parameters. Various other bioreactor systems alongside stirred suspension are available for stem 
cell culturing and they are listed in the table below with their main characteristics (Table 2.4). 
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Table  2.4: The main characteristics of different bioreactors used for stem cell culture (63, 92). 
Bioreactor 
Configuration 
Advantages and Disadvantages 
Stirred suspension 
Bioreactor (96) 
• Economical and easy to control 
• Homogeneous system can be achieved; minimal concentration gradients 
• Allows both suspension and adherent growth (when microcarriers are used) 
• Online monitoring and control is possible  
• Hydrodynamic shear stress due to agitation can be detrimental to cells 
Roller bottles (97) 
• Only allows anchorage-dependent cell culture 
• Low-cost solution  
• Concentration gradients are minimized, but still exist within medium 
Wave bioreactor  
• Monitoring and control solutions are widely available  
• Disposable system and easily scalable  
• Sampling, monitoring and control are not as straightforward as with other 
systems 
Rotating wall vessel 
bioreactor 
• Better stem cell expansion I shorter time period 
• Low-shear stress  
• Efficient gas transfer  
• Complex system 
• Not easily scalable  
• Build-up of toxic metabolic byproducts is minimized 
Hollow-fibre 
bioreactor 
• Low shear stress environment 
• Concentration gradients are formed within the system 
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Fixed and fluidized 
bed 
Bioreactors 
• Spatial concentration gradients exist (in fixed bed) 
• Better mimic of the in vivo system (3D scaffold) 
• Potential shear stress effects (in fluidized bed) 
• Difficulties in scaling-up 
2.4 Bioreactor Configuration and Parameters 
Selecting optimal culture parameters for ex vivo expansion is a significant challenge. Generally, 
it involves numerous parameters that require both close examination and management to ensure 
optimal and accurate results of cell proliferation. Alongside suitable temperature and pH values, 
the proliferation of cells is dependent not only on the supply, distribution, and uptake of O2 and 
nutrients (glutamine, glucose, and others), but also on the production of growth modulating 
chemical substances. Altering these parameters creates variations within the bioreactor system 
that can be used to direct cell behaviour in vitro (63-65). Hence, strategies are essential such that 
process and inconsistency are minimized whereas efficiency is maximized. These strategies 
consist of precise monitoring and accurate control of the overall system to achieve process 
standardization.  
The stem cell culture niche is overall very intricate and mimicking it in vitro involves of precise 
monitoring and accurate control of the overall system to achieve process standardization and to 
enhance stem cell proliferation. Altering these parameters creates variations within the bioreactor 
system that can be used to direct stem cell behaviour in vitro (63-65). This is discussed in more 
detail in the next few sections. 
2.4.1 Oxygen 
Of the many parameters that regulate and influence ESC proliferation and/or differentiation in 
bioreactors, O2 tension is probably the most critical component of this microenvironment (63-
65). In cell culture, O2 tension directly affects stem cell proliferation via altering the production 
of growth factors, surface markers, transcription factors and by also interfering in the cellular 
respiratory pathways (68).The literature broadly illustrates that hypoxic conditions (low O2 
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concentrations of about 2-5%) are favoured in order to retain ESC pluripotency, while normoxic 
condition (atmospheric O2 concentrations of about 20%) enhance the proliferation and expansion 
of mature cells (66). ESCs can only be obtained in relatively low numbers and hence need to be 
cultured and grown into large numbers in vitro; if this cultivation were to be undertaken at 
atmospheric O2 levels, not only would the cells be triggered to differentiate (thus loss of 
pluripotency), but cell viability would also decrease as a result of oxidative stress (63). Cell 
proliferation is more likely maintained by decreased O2 levels (2-5%) so as to mimic cellular in 
vivo environment within the BM which is almost anaerobic. Nevertheless, significantly low O2 
concentrations (0-1%) have been reported to induce a state of dormancy in cell cultures and thus 
halt cell expansion (66). 
Optimal culture conditions that favour an increase in viable cell proliferation were investigated 
by dos Santos et al., who focused on the effect of low O2 levels (2%) on human mesenchymal 
stem cells (MSC) proliferation kinetics and metabolism (63, 98). Their results illustrated two 
important points; first, that MSC expansion was more efficient at 2% O2 levels when compared 
to those at normal O2 levels (98), and that mouse neural ESCs showed higher levels of 
proliferation at 2-5% O2 levels also in contrast to cells at normoxic conditions (63, 98). Stem cell 
proliferation is not only enhanced in hypoxic conditions, but apoptosis is also reduced (99).   
In several studies on murine ESCs, O2 tension has also been shown to have considerable effects 
on the differentiation of these cells (63, 99). Low O2 levels could lead to spontaneous 
differentiation if it is not properly controlled (63). Bauwens and co-workers revealed that 
hypoxic conditions increased the yields of cardiomyocytes (12), while Dang and colleagues 
demonstrated that these conditions increased the yields of hematopoietic cells (63).  
Oxygen partial pressure was also demonstrated in the literature to significantly affect the 
expansion of pluripotent cells. Serra et al. conducted an experiment whereby two bioreactors 
were monitored and controlled for O2 partial pressure in parallel (100). The group controlled pO2 
at 5% and 30% air saturation in each bioreactor respectively. They found that with higher air 
saturation (30%), cell expansion was enhanced by day 11 to almost three times that of the 
bioreactor with lower air saturation (100).  
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According to cell differentiation with respect to O2 levels, some debate exists in the literature. 
Ezashi et al. reported that hypoxic conditions of approximately 5% O2 caused a reduction in cell 
differentiation in comparison to that of normoxic condition (21% O2). However, Chen and co 
workers illustrate that both concentrations of O2 have no significant effect on the cells in terms of 
differentiation (101, 102). 
2.4.2 Carbon Dioxide and pH 
Discussed in Sections 1.5 and 2.1. 
2.4.3 Metabolic Byproducts 
Cell proliferation and respiration are fuelled by carbon and nitrogen sources. Glucose and 
glutamine are the two key sources of these substrates in cell culture (68). Nutrient and metabolite 
concentrations can also have unfavourable effects on the stem cell fate in the culture in terms of 
cell proliferation, differentiation, and/or death. ESCs require an energy source for proliferation; 
however, these metabolic byproducts are also produced during the culture and need to be 
monitored. High levels of the latter generate an acidic environment where pH decreases 
throughout the cell culture process (63, 68). Consequently, these unfavourable conditions could 
initiate cell death or a hindrance in cell proliferation (63). From this, in order to generate stem 
cells in decent numbers while sustaining their pluripotency, close monitoring and control of 
nutrient and metabolite levels is essential. Alongside monitoring, the cell culture can also be 
maintained by replacing, or partially replacing, the cell medium with fresh medium so as to 
dilute the concentration of the toxic metabolites and provide additional nutrients for the cells.  
2.4.4 Sheer Stress 
Another factor that is prone to have a detrimental effect on the in vitro stem cell culture is 
hydrodynamic sheer stress (impeller speed, diameter, geometry/position) (63). The stem cells 
will be grown in stirred suspension where agitation gives rise to an energy transfer from the 
stirring bar to the medium (63). This generates areas of strong disorder and instability within the 
bioreactor which, in turn, initiates localized sheer on regions such as the surface of cell 
aggregates, cells attached to microcarriers, or single cells in suspension, which results in cell 
damage/death (63). Moreover, shear stress can also be a stimulus for the differentiation of the 
stem cells (63). Agitation is however necessary within the cell system to allow for uniform 
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distribution of medium and nutrients amongst the cells and consequently a homogeneous 
environment (103). With an increase in revolution per minute (rpm) and impeller size, there is an 
increase in hydrodynamic shear stress (93); it has been reported that stem cell proliferation is 
impeded at rpm values of 120 and over where the cells enter necrosis (104). HSCs are relatively 
sensitive to shear; stirring at 60rpm can be harmful (69). A challenge we face here is finding the 
optimal levels of agitation and the most favourable stirring conditions within the bioreactor that 
the cells will need in order to grow to a maximum number while maintaining their survival and 
proliferative capability.  
Simultaneously, the methods of pumping gases (O2 or CO2) into the bioreactor must be taken 
into consideration; this is because forcing gas bubbles into the medium and/or vigorous stirring 
may also be a reason of stem cell damage/death (63). Rapid gas sparging creates turbulence with 
the medium itself. This not only results in hydrodynamic shear stress at the cellular membranes, 
but also in the physiological damage of the cell and thus the cease of its ability to function (63). 
Nevertheless, it has also been accounted that the insertion of probes/sensors into the medium also 
increases shear stress since the latter disrupt flow patterns (105).  
In this project, we have chosen to specifically focus on CO2; yet, it is not sufficient to merely 
focus on this parameter alone, for the culture environment itself is just as significant in achieving 
maximum cell densities. Hence, a detailed literature review on the culturing of HSCs in 
bioreactors was conducted and is presented in the following sections. This was in order for us to 
draw a clear picture of the optimal bioreactor system for our cells in. From this literature review, 
an individual bioreactor was designed and manufactured to not only meet literature 
recommendations/achievements but to also comply with our requirements in order to confirm the 
potential of cell proliferation in 3D systems compared to 2D ones with the above parameters 
taken into consideration.  
2.5 Bioreactor Configurations and Operations 
2.5.1 Brief Introduction and Scope of Review 
From the literature, it can be noted that the optimization of HSC cultivation in a bioreactor has 
only been narrowly investigated (91). The in vitro propagation of HSCs in bioreactors is still in 
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its infancy and remains largely under-developed. The development of such stable systems will 
potentially provide valuable means for the investigation of signal transduction mechanisms that 
influence hematopoiesis and hematopoietic malignancies, such as leukaemia (106). Moreover, 
uniform ex vivo systems will aid in the comprehension of the dynamics and mechanisms of cell 
differentiation and hematopoietic cell-development (106). 
Growing and expanding HSCs in bioreactors was initially put forward to overcome traditional 
shortfalls in the standard cultivation methods using TCP-flasks. Various bioreactor designs have 
been conceptualised and engineered for HSC-cultivation since the 1990s (107, 108). The latter 
include stirred tank (109), fixed bed (110, 111), airlift (112), membrane (112), and perfusion 
bioreactor (113, 114). Reviews on bioreactor applications for HSC cultivation and stem cell 
cultivation in bioreactors can be found in the literature (23, 63, 107, 115).  
The following sections provide a broad literature review on studies that have investigated the 
proliferation/expansion of HSCs in 3D bioreactor systems, under either uncontrolled or 
controlled (traditional or model-based control) conditions. Please refer to Appendix for a 
summary of Sections 2.6 and 2.7. 
2.6 Uncontrolled HSC proliferation 
The cell type required for BM transplantation differs depending on the type of application. The 
cells that are suggested for short-term rapid recovery of the hematopoietic system are the mature 
progenitors: colony-forming unit-granulocyte macrophage (CFU-GM). However, patients 
undertaking ablative chemotherapy and radiotherapy treatment critically require long-term 
reconstitution; in this case, patients depend mostly on primitive stem cells: long-term culture-
initiating cells (LTC-IC) (116). 
Retrospective assays are employed to quantitatively measure the adequacy of hematopoietic cells 
during their earlier stages of differentiation to produce certain quantities and forms of adult blood 
cells under maximally stimulatory conditions (117). Through these assays, several CFC types 
alongside more primal LTC-IC are distinguished in vitro (117, 118). LTC-IC support both 
human and murine hematopoietic cell differentiation, or hematopoiesis, and are deemed HSCs 
(119) which is why most HSC bioreactor cultivation and/or optimization studies mainly 
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concentrate on improving CFC and LTC-IC yields as an indication of cell expansion (118). 
CD34
+
 analysis by means of flow cytometry (FCM) is another method used to evaluate the 
competence of HSC, especially prior to a BM transplant (69, 118). Although these in vitro assays 
may correlate with the stem cell content within a given HSC sample, they are not however 
competent enough to give an absolute measure of HSC content over a broad range of conditions 
(69).  
As discussed in Chapter 1, the in vitro culture of human hematopoietic cells is of high clinical 
importance and has more recently started to receive significant attention. The more popular 
methods utilised for the proliferation and expansion of these cells include static 2D culture 
methods with only fewer reports that discuss the use of 3D culture systems (109). 3D culture 
systems can be both static and dynamic. Bioreactor cell cultivation allows for the monitoring, 
control, and optimisation of the process. From the literature, it can be noted that the optimisation 
of HSC cultivation in a bioreactor has only been narrowly investigated (91). Furthermore, even 
fewer reports exist on the use of bioreactors coupled with strict control and optimisation of 
variables. This review will now discuss papers that have explored non-controlled and non-
optimised HSC expansion in 3D bioreactor systems. 
The earliest documentation of an in vitro liquid-culture system for the cultivation of progenitor 
hematopoietic cells was in the very early 1970’s by Dexter et al. (120, 121) in 2D dishes. It was 
not until 15 years later that an 8-12-fold expansion of murine pluripotent hematopoietic cells in 
vitro was reported in four days of culture, also in 2D dish, by Iscove et al. (122). In 1990, 
Naughton et al. suggested the culturing of HSCs in a 3D culture system (suspended nylon mesh 
system). The group developed this intricate 3D microenvironment to support hematopoiesis over 
a 12-week experimental period. They found that after analysis, both human and rat BM cultures 
revealed multi-lineage hematologic expression and active proliferation of immature cells (123). 
Also in 1990, Knazek et al. showed that human tumour infiltrating lymphocytes (TIL) could be 
expanded efficiently in a hollow fibre bioreactor system (Cellmax) reaching 124-1170-fold over 
a 14-32 culture day period with an average viability of 91%. The cell characteristics were 
analysed and shown to be similar to TIL grown in gas-permeable culture bags. The group 
estimated that this protocol would help decrease technical laboratory time expended by 80% and 
would also decrease incubator space required (124). 
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2.6.1 Stirred suspension 
Stirred suspension bioreactors were first used for HSC cultivation by Sardonini and Wu (1993) 
(112) who analysed and compared the expansion and differentiation of low-density mononuclear 
cells (LDMC) obtained from human BM in static culture (T-flasks) and in various bioreactors 
(suspension, microcarrier, airlift, and hollow fibre). Cell cultures in all cases were carried out via 
the use of added cytokines. It was reported that the total cell expansion in static culture ranged 
between 4.4- and 32-fold. Using a normalized value of 1 for static cultures, LDMC expansion in 
the suspension bioreactor reached a value of 1.6 under the same conditions, which was the 
highest of all bioreactor types (112). 
Zandstra et al. also developed a successful system for the production of human hematopoietic 
progenitors in stirred suspension bioreactors. The group investigated the potential of stirred 
suspension bioreactors to support hematopoiesis from a starting inoculum of human BM cells 
with growth factor supplements. Their results showed that after four weeks of stirred culture, the 
number of total viable cells and CFC increased by 16- and 22-fold, respectively (117). Zandstra 
et al. then conducted a series of experiments to investigate the parameters that may hinder the 
cytokine-mediated expansion of primitive HSCs in stirred suspension cultures of normal human 
marrow cells. First, cells were exposed to specific cytokine concentrations and the group 
achieved a 45-fold expansion in CFC numbers within two weeks along with a 2.5-fold expansion 
of LTC-IC (125). Afterwards, the cells were exposed to a 5-fold higher level of these cytokines 
and expansion in two weeks was enhanced to 66-fold and 9-fold of CFC and LTC-IC, 
respectively (125). Similarly, Kwon et al. reported a 5-fold and 4-fold increase in hematopoietic 
primitive progenitor cells (stem-cell-antigen-1 positive cells) and LTC-ICs, respectively, when 
murine HSCs were cultured in 50 ml stirred bioreactors for 14 days (119). 
Collins et al. evaluated glucose and lactate metabolic rates for hematopoietic cultures of CB 
mononuclear cell (MNC), PB MNC, and PB CD34
+
 cells in spinner flasks and in T-flasks using 
both serum-containing and serum-free media (model-based control). It was reported that the time 
of maximum CFC counts in each culture directly coincided with the time of maximum glucose 
uptake and lactate production for a broad range of seeding densities and cytokine combinations. 
A two-population model was developed to illustrate
 
lactate
 
production for cell cultivation in both 
T-flasks and spinner flasks. The group concluded that this model could potentially be employed 
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to predict harvest time which directly correlates to maximum CFC percentage in culture (126). 
After this, Collins et al. then analysed the same hematopoietic cell cultures for their proliferation 
and expansion in stirred bioreactors in both serum-containing and serum-free medium 
(traditional control). This study is the first to analyse the proliferation of hematopoietic cells in 
serum-free stirred bioreactors. It was reported that all cell cultures proliferated well in the 
spinner flasks in comparison to that in T-flasks in both medium types. The group also stated that 
proliferation of these hematopoietic cells in the spinner flasks was dependant on agitator design, 
rpm, and also seeding density, where serum-free cultures required a higher inoculum density. 
Finally, it was noted that serum-free spinner flask culture- proliferation was comparable to that 
observed in serum-containing medium (127). 
A study by Kim et al. developed a large-scale suspension bioreactor system for the production of 
clinically relevant numbers of CFU-GM from an initial small inoculum of BM aspirate (for 
short-term rapid recovery of hematopoiesis). The group first conducted factorial experiments 
with three variables to investigate the effects of three variables (initial cell density, medium 
exchange rate, and supplement of stroma-conditioned medium) on the expansions of total cells 
and CFU-GM. Highest levels of total cells and CFU-GM were observed in cultures with a high 
initial cell density (10
6
 cells/ml), a high medium exchange rate (20-40% (v/v) per day), and 
supplemented with stroma-conditioned medium (116). Large-scale suspension cultures were then 
performed with high initial cell density and medium supplemented with growth factors. The 
numbers of total cells and CFU-GM expanded to an average 8- and 5-fold respectively over a 14-
day period. Subsequent runs were performed with different growth factors and supplemented 
with stroma-conditioned medium where total cells and CFU-GM numbers increased to 3- and 
17-fold over a 14-day period (116). 
Xiong et al. evaluated the effects of expanding and maintaining multipotency of human 
umbilical CB hematopoietic progenitor cells in a novel 3D system, CultiSpher G, in stirred 
suspension mode in the presence of cytokines and stromal cells.  At day 12, CFU-C and CD34
+
 
cells were 23.3-, and 9.6-fold in the 3D system, respectively, in comparison to 19.2-, and 3.4-
fold in the 2D system, respectively (128). 
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Jing et al. examined the effects of agitation speed on the ex vivo expansion of CB HSCs in stirred 
flasks. The group noted significantly higher CD34+ percentages at 30 rpm in contrast to 60 and 
80 rpm, 3.01  0.26 versus 2.13  0.24 and 1.39  0.19, respectively (129). 
2.6.2 Perfused Systems 
Wang et al. reported the development of a novel continuous perfusion bioreactor for long-term 
BM cultivation (LTBC) in 1992 (130). The group first investigated the ability of the bioreactor to 
support LTBC at incubation temperatures of 33
o
C and 37
o
C. Highly porous collagen 
microspheres were introduced to the bioreactor to provide a natural extracellular matrix and an 
increased surface area for cell attachment, interaction, and proliferation. The bioreactor was 
found to successfully support hematopoiesis in vitro for at least four months with continuous 
output of viable hematopoietic cells and at both temperatures (130). 
Koller et al. describe methods for the large-scale expansion of human hematopoietic LTC-IC and 
progenitor cells from BM MNCs also in a continuously perfused bioreactor system. The cells 
were cultured for 14 days and an overall 10- and 7.5-fold expansion was obtained for total cell 
number and LTC-IC, respectively (131). The group reported that overall, three billion cells were 
produced from the equivalent of a 10-15 ml BM aspirate (131). 
Oh et al. designed experiments to identify factors that reduce the ex vivo single batch expansion 
of BM cells in perfusion-based bioreactor systems long-term. It was reported that harvesting half 
the cell population periodically can lead to extended culture periods by means of increasing the 
size of the proliferation surface area required (132). Based on cell expansion that could 
potentially be obtained from the harvested cell population, the group was able to achieve a 
calculated cell expansion exceeding 100-fold, and a CFU-GM expansion exceeding 30-fold over 
a 27-day culture period (132). 
In more recent work, Schmelzer et al. developed and compared multicompartment hollow-fibre 
membrane-based 3D perfusion bioreactor for the long-term cultivation of human BM MNCs 
with and without hydroxyapatite scaffolds mimicking the in vivo bone matrix (133). The cells 
were analysed for gene expression, surface markers, metabolic activity, hematopoietic potential, 
viability, and attachment. The group found that the 3D perfusion bioreactor culture enabled long-
term maintenance of primary human BM cells with the hydroxyapatite scaffolds (133). 
 39 
 
2.6.3 Packed Bed 
Wang et al. developed a LTBMC system composed of a packed-bed bioreactor and initiated with 
murine BM with packed, highly porous bovine collagen microspheres as the matrix support for 
BM cell proliferation. When compared to cultures grown in conventional 2D flasks, it was found 
that cultures grown in the bioreactor grew in a 3D configuration comparable to that in vivo. This 
group also reported that cell output from the 3D culture system at 37
o
C was practically 
equivalent to that at 33
o
C; also, multilineal differentiation of the HSCs was achieved through this 
system in the absence of growth factors (excluding those in the serum) (134). However, a 
drawback to the use of these collagen spheres is that the porous lattice structure which is an 
arrangement of pores (200-300 m) is closer to providing a 2D local microenvironment for the 
cells as opposed to the 3D space assumed in the BM (135). 
Mantalaris et al. developed a 3D BM culture system in which marrow cells were also cultivated 
in a bioreactor packed with porous microspheres. The overall system was configured to mimic 
the in vivo BM for the ex vivo erythropoiesis of human cells. The group reported erythroid cell 
production that lasted for more than 5 weeks with 60% erythroid cells in the non-adherent cell 
population in contrast to erythropoiesis in standard 2D flask cultures. The group also reported 
that microscopic examination of a thin section of the spheres showed the marrow cells 
populating the pores in a 3D manner with cell-cell contact, resembling interactions within the 
BM tissue in vivo (136). 
2.6.4 Hollow Fibre 
Malone et al. characterized human TILs expanded in hollow-fibre bioreactors, as an alternative 
to semi-permeable bags and roller bottle systems, for therapeutic use in cancer patients. The 
group reported that the mean number of days required to reach successful initiation for all 
tumour types was 29  16 days, while therapeutic doses of TIL required an average of 88  23 
days. The overall success rate and characteristics of TIL expanded in the hollow-fibre bioreactors 
were proven similar to those of TIL expanded in semi-permeable plastic bags (137). 
Recently, Xue et al. developed an ex vivo 3D bio-mimetic co-culture platform using a hollow 
fibre bioreactor for HSC expansion. The efficiency of the overall system was determined via 
comparison to identical data from cultures in 2D T-flasks. The group revealed that both systems 
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showed comparable results in terms of supporting total cell and CD34
+ 
progenitor cell expansion, 
as well as cell performance; however, cells collected from the 3D systems had higher clonogenic 
ability (138). 
2.6.5 Spinner Flasks 
Levee et al. reported a 12- to 24-fold multilineage expansion of adult human BM cells in 16 to 
19 days via the use of alginate-poly-ʟ-lysine microencapsulation systems combined with rapid 
media exchange in glass spinner flasks (139). The group stated that visually identifiable colonies 
within the capsules were accountable for the cell expansion; further suggesting that 
microencapsulation of human HSCs permits the outgrowth of progenitor cells and could provide 
a novel culture system for the examination of HSC- proliferation and differentiation (139).  
A comparative gene-expression analysis of CD34
+
 hematopoietic stem and progenitor cells 
(HSPC) grown in static (well plates) and 3D stirred (spinner flasks) culture systems was 
conducted by Li et al. The gene expression profiling of CD34
+
 HSPCs of both systems was 
compared using SMART-PCR and cDNA arrays in order to understand the genetic differences 
provoked by culture environments. Apart from acquiring higher CD34
+
 and CFC counts in the 
stirred cultures in comparison to the static ones, the group’s analyses also showed that 103 and 
99 genes were significantly expressed in CD34+ cells from static and stirred systems, 
respectively. Similar levels of expression were found in 91 of those genes, while 12 showed 
differential transcription levels (140). 
2.6.6 Rotating Wall Vessel Bioreactor (RWVB) 
Kedong et al. showed that UCB-HSCs and UCB-MSCs can be successfully expanded and 
harvested simultaneously in a rotating wall vessel bioreactor (RWVB) in the presence of low 
doses of cell factors when using microencapsulated feeder cells and glass-coated styrene 
colpolymer microcarriers. The co-culture was also performed within well plates and spinner 
flasks for comparison. The fold expansion of total cell numbers in the RWVB, CFU-C, 
CD34
+
/CD45
+
/CD105
-
 (HSCs), CD34
-
/CD45
-
/CD105
+ 
(MSCs) and after 12 days of culture were 
(3.7  0.3)-, (5.1   1.2)-, (5.2  0.4)-, and (13.9  1.2)-fold, respectively. The group 
demonstrated that these values were significantly superior to those obtained from well plates and 
spinner flasks (141). Kedong et al. then demonstrated that the expansion of UCB-HSCs can be 
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achieved at a large scale with the support of microencapsulated stromal cells using a RWVB 
(with traditional feedback control) (142). The microencapsulated MSCs support the expansion of 
HSCs through soluble growth factors, and the RWVB provides an environment that is favoured 
for dynamic co-cultures. The group reported the expansion of total cells, CD34
+
 cells and CFU-
Cs at day 7 of culture to be (107.05  6.08)-, (26.52  1.5)-, and (19.2  3.18)-fold expansion, 
respectively, which were significantly higher than that observed in 2D tissue-culture plates. 
Yuan et al. encapsulated human CB MNCs in alginate 3D static and RWVB systems. The cell 
number amplification, CD34
+
 expansion, and the colony forming capacity of these systems was 
compared to those of the standard 2D system. The group reported that the 3D alginate culture 
systems displayed higher efficacy in CB HSC proliferation for extended periods without loss of 
pluripotency (143).  
2.6.7 Other 
Banu et al. developed a LTBM bioreactor culture system and analysed the maintenance, 
preservation, and colony activity of CD34
+
 cells cultured for three to six weeks with various 
lower concentrations of cytokines than those more commonly used. Cells were grown in a novel, 
3D, porous cell-growth matrix (Cellfoam) (144). Lower cytokine concentrations were chosen 
in order to mimic the steady state in vivo hematopoietic environment and were found to expand 
certain components of the heterogeneous CD34+ hematopoietic progenitor cell population. 
Expansion was also noticeably higher in the 3D systems in comparison to that in the 2D plastic 
dishes (144). 
A modern commercially available bioreactor (Dideco ‘Pluricell System’) was used by Astori et 
al. in recent preclinical and murine studies in which the group demonstrated an MNC and CD34
+
 
fold expansion of 230.4  91.5 and 21.0  11.9, respectively, after 12 days of culture. This 
bioreactor is a closed system that contains an expansion chamber and uses serum-free medium 
and was showed improved engraftment in sublethally irradiated severe combined 
immunodeficient and non-obese diabetic mice models (145).  
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Figure  2.1: New-type bioreactor developed by Zhou et al. which combines elements of both 
static and stirred culture systems (146). 
1: grooved culture chamber; 2: medium inlet; 3: medium outlet; 4: cell inoculation port; 5: 
surface protuberance; 6: complementary flask; 7: gas mixture appliance. 
Zhou et al. developed a new-type bioreactor (Figure 2.1) which combined elements of both static 
and stirred culture systems and then compared HSC/Progenitor cells ex vivo expansion in both. 
Proportions and fold expansion of CD34
+
 cells in both static and cyclic systems were close. 
However, static displayed favourable results in total expansion of cells, while cyclic had a mean 
proportion of CD34
+
CD38
-
 four times of that in static culture. Through these results, the group 
demonstrated that the static culture environment more closely encouraged HSCs to differentiate 
into progenitor cells, while the cyclic culture system was more efficient in the expansion of 
primitive HSCs (146).  
Higuchi et al. reported the development of a direct ex vivo HSC expansion method which 
involves faster filtration of umbilical CB through polyurethane foaming membranes as opposed 
to conventional methods of HSC-purification (147). The group then used 3D bioreactor systems 
for HSC expansion and achieved increased numbers of total cells (6.6- to 45.7-fold) (147). 
A simple eccentric stirred tank mini-bioreactor was characterized in terms of mixing 
performance and culture adequacy by Bulnes-Abundis et al. (148). The group used laser induced 
fluorescence experiments and computational fluid dynamics computations to determine optimal 
conditions required for adequate mixing (eccentricity of impeller shaft, round bottom tank, 
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inclination of impeller disc). Using this system, human HSCs were expanded tenfold in 
suspension with no pH and DO monitoring nor control (148). 
2.7 Traditional Control (Feedback Control) of HSC proliferation  
As outlined above, HSC have extensive potential applications in both research and medicine. 
The chief aspect these applications have in common is the requirement of a large population of 
HSCs. In order to meet this prerequisite, the following conditions must be met: (a) maximized 
cell expansion in minimum time, (b) straightforward cell harvest protocols, (c) controlled cell 
culture system, and (d) clinical/therapeutical validity. 
(a) In the case of leukaemia patients, for example, patients will require the largest number of 
cells possible for successful stem cell transplantation. These cells must not only be 
patient-specific, but must also be cultured during the chemotherapy procedure (in a 
maximum of two weeks). Hence, cells will be required ‘on demand’ and in adequate 
numbers per patient (149). The cultivation vessel (bioreactor) must also accommodate for 
two important points: (i) a small amount of cells in the early stage of culture, (ii) a 
considerable increase in cell number and volume during the cultivation without 
disturbances to the conditions and control of the overall system (149). 
(b) A facile method of harvest must be prepared when the cells are finally required for 
transplantation. This method must minimize both cell loss and damage in order to 
maximize the value of the transplant and minimize any chances of contamination. 
Moreover, this method must be both time and economically efficient. 
(c) As we illustrated above in great detail, control and optimization of HSC-culture systems 
is integral bearing in mind the many parameters that directly influence the proliferation 
and expansion of these cells. Minor alterations in any of these parameters can lead to 
considerable variations in the proliferation and/or differentiation of HSCs proliferation 
patterns. 
(d) The vast majority of HSC culture systems use either cell lines of animal origin, or animal 
serum. These must be taken into careful consideration when contemplating human 
clinical use. 
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This review will now summarize and discuss papers that have explored the traditional control of 
mammalian HSC expansion in 3D bioreactor systems. 
2.7.1 Perfused Systems 
Early studies conducted by Koller et al. examined the effects of reduced O2 tension and 
perfusion in long-term hematopoietic cultures (150). The group revealed that reduced O2 tension 
increased total cell numbers by 5-fold in CB suspension cultures. Moreover, the low O2 levels, 
which more closely approximate the in vivo environment, not only favoured increases in both 
number and frequency of CFCs, but also enhanced the proliferation and maintenance of human 
stromal and progenitor cells in vitro. Finally, the group revealed that continuous medium 
perfusion alongside the low O2 tension increased total cell production when compared to static 
cultures under ambient O2 (150). 
Palsson et al. explored the dependence of human HSC proliferation on gas phase O2 
concentration, seeding density, and time of cell harvest. The cells were cultivated in continuous 
perfusion bioreactor systems under specific operating condition; the group was able to achieve a 
population of human mononuclear BM cells which expanded up to 20- to 25-fold over a 14-day 
period (151). 
Van Zant et al. compared the efficacy of the ex vivo expansion of UCB and mobilised PB in 
continuous perfusion bioreactors to produce clinically relevant numbers of stem/progenitor cells. 
Under ideal conditions (inoculum density, growth factor combinations, presence/absence of 
allogeneic stroma) total cell density, CFU-GM and LTC-IC populations in mobilised PB were 
expanded by approximately 50-, 80-, and 20-fold, respectively, over 14 days. After evaluating 
UCB in the same manner, a 40- to 60-fold expansion of CFU-GM was reported which was 
equivalent to a 40-fold expansion in comparison to the inoculum (152). 
Sandstrom et al. explored the ex vivo expansion of PB MNCs cultured both directly and after 
CD34
+
 selection in both static and continuously perfused cultures. Cultures were inoculated with 
either MNCs or CD34
+
 cells. The group revealed that similar average total cell expansion was 
observed in both static and perfused cultures for both MNC and CD34
+
 cell cultures (153). 
However, perfusion cultures were shown to maintain higher concentrations of LTC-IC for both 
MNC and CD34
+
 cell cultures (153).  
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Meiβner et al. developed and compared two continuously perfused systems for the cultivation 
and expansion of human hematopoietic progenitor cells: fixed bed and fluidized bed bioreactors. 
It was reported that the fixed bed bioreactor system was the favoured model for cultivation and 
expansion of these cells, where the group reported a permanent production of progenitor cells 
and mature blood cells and the expansion of very early progenitor cells and later progenitor cells 
up to 4.2-fold, 7-fold, and 1.8-fold, respectively (111). However, this system was found to be 
unsuccessful due to its insufficient capability of expansion of MNCs and the difficulty associated 
with harvesting the cells from the scaffold matrix (135). 
Bachier et al. evaluated the use of ex vivo cultured progenitor cells for hematopoietic restructure 
following high-dose chemotherapy in breast cancer patients. Controlled perfusion bioreactors 
were used for the ex vivo expansion over a 12-day culture period. The inoculum of BM aspirate 
consisted of a total of 675–1125  106 MNCs; Median fold expansion of nucleated cells, CFU-
GM, CD34
+
lin
-
, and LTC-IC was 4.9, 9.5, 0.42, and 0.32, respectively (154). It was shown that 
ex vivo expansion of progenitor cells from an initial small volume of BM aspirate in perfusion 
bioreactor systems permits hematopoietic reconstitution after high-dose chemotherapy (154). In 
a similar study, Chabannon et al. also reported a clinical pilot study whereby the feasibility and 
safety of producing hematopoietic progenitor cells from a small marrow sample for clinical use 
after high-dose chemotherapy in breast cancer patients was investigated (155). A small aspirate 
of BM was obtained and used to inoculate two bioreactors over a 12-day culture period. Fold 
expansion of total cell number and CFU-GM ranged from 3.32 to 4.94, and 0.52 to 26.6, 
respectively (155). 
An automated continuous perfusion culture vessel (AastromReplicell) for HSC expansion was 
developed by Aastrom Biosciences and was used by Stiff et al. for the expansion of BM MNCs.  
Nineteen breast cancer patients then underwent autologous transplantation exclusively using the 
ex vivo expanded small aliquot of BM cells after chemotherapy. Hematopoiesis was maintained 
at 24 months in 18/19 of the patients, and no tumour cells were observed in any of the patients 
after the expansion and transplantation. Hence, the group demonstrated that is feasible to 
perform autotransplants solely using BM cells grown in ex vivo perfusion bioreactors starting 
from only a small aliquot (156). 
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The AastromReplicell was also used by Jaroscak et al. for the ex vivo expansion of UCB. The 
group then performed phase 1 trial augmenting conventional UCB transplants with the ex vivo-
expanded cells. Results revealed that UCB cells could be expanded in 12 days where CFU-GM 
counts were maximal, but CD34
+
lin
-
 counts were poor. The expansion system was proven safe 
since the patients did not experience any adverse effects from the infusion of the expanded cells 
(157). 
2.7.2 Stirred Suspension 
Collins et al. illustrated hematopoietic cell expansion with controlled pH and DO in a stirred 
bioreactor. The group reported that, and through the use of a cell-dilution feeding protocol, the 
maximum specific O2 consumption rate for each culture closely matched the maximum 
percentage of CFCs within that culture. Glycolysis was also monitored within this research via 
the examination of the ratio of lactate production to O2 consumption and it was concluded that 
post-progenitor cells of the granulomonocytic lineage obtain most of their energy from 
glycolysis than do CFCs; thus monitoring metabolic parameters will allow the estimation of the 
percentages of both CFCs and more mature cells in culture (158). 
McDowell and Papoutsakis investigated the effect of increases in agitation intensity on receptor 
surface content and mRNA levels in CD13 cells, and on the metabolism of HL60 cells in stirred 
tank bioreactors. It was concluded that agitation had a dose-dependent effect on the proliferation 
of HL60 cells cultured in 5% foetal bovine serum (FBS) and that HL60 metabolism was dose 
dependent upon the agitation rate (159). This group then went on to examine the effect of serum 
concentrations in cell media on the CD13 receptor surface content and mRNA levels of HL60 
cultured in agitated bioreactors. Increased serum levels were found to increase CD13 receptor 
expression, reduce the transduction of fluid-mechanical forces, and reduced glucose 
consumption/lactate production rates (160). McDowell and Papoutsakis then assessed the effect 
of decreasing extracellular pH on the CD13 receptor content and HL60 metabolism. It was 
reported that reduced pH levels lead to increases in CD13 surface receptor content, decreases in 
HL60 average size, and lower glucose consumption/lactate production rates (161). 
De León et al. designed, characterized and applied a mini-bioreactor for the culture of human 
hematopoietic cells from umbilical CB. The system described is composed of mini-bioreactor 
coupled to a data acquisition and control system which continuously monitored pH, DO and 
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redox potential (Figure XX). A 10-, 9.2-, and 14-fold expansion of hematopoietic progenitors 
CFU-GM, total CFU, and MNC, respectively, was achieved in cultures controlled at 20% DO 
levels. Characteristic variations of O2 uptake rate and culture redox potential were also 
determined for human hematopoietic cells in batch cultures with constant and predetermined pH 
and DO values (109). 
 
Figure  2.2: Schematic diagram of the minibioreactor and data acquisition and control system 
used for the expansion of human hematopoietic cells (109). 
Ratcliffe et al. demonstrated the potential of an automated replicate suspension bioreactor system 
with online monitoring and control to develop a HSC proliferation and differentiation process for 
erythroid committed cells (162). The group reported that cell proliferation was directly related to 
seeding density and O2 levels. Cells reached up to 6 population doublings over a 10-day culture 
period from a starting cell density of 4  104 cells/ml, with 7.5-15% DO. The data reported 
demonstrated that HSCs can be cultured at a 10 ml suspension scale, which was the lowest 
reported to date. 
2.7.3 Packed Bed 
The in vitro expansion of murine BM cells in airlift packed bed bioreactor systems was 
investigated by Highfill et al. In this paper, the optimal inoculation density of stromal cells was 
first determined; these cells were then subsequently seeded with fresh BM to initiate 
hematopoiesis. The metabolic activity in the immobilized bioreactor was analysed by measuring 
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concentrations of glucose and ammonia. It was reported that the metabolic activity and cell 
nature in systems with non-conditioned medium, conditioned medium from non-active cultures, 
and conditioned medium from active cultures varied significantly (163). The group then 
investigated the cultivation of BM cells in a large-scale airlift packed bioreactor system with pH 
and DO control. The culture was monitored for HSC proliferation, glucose uptake, and lactate 
production. The 500-ml perfusion culture system yielded 3.6  108 suspended BM cells over the 
course of 11 weeks (164).  
2.7.4 RWVB 
Liu et al. showed that it is more efficient to expand UCB-HSCs and progenitors using a RWVB 
in contrast to standard T-flasks. Cells were cultured for eight days and media was monitored for 
pH and osmolality every 24 hours. At the end of the culture time, the total cell number, CD34
+
 
count, and CFU-GM count increased (435.5 ± 87.6)-, (32.7 ± 15.6)-, and (21.7 ± 4.9)-fold, 
respectively, as opposed to very mild changes in counts for cells grown in the T-flasks. This 
group also proposed that in order for an adult weighing 80 kg to receive an UCB transplant, two 
feeding-protocols and four RWVBs (500 ml each) would be required to provide a sufficient 
number of cells in six days (165). 
2.7.5 Hollow Fibre 
Whole blood (WB) is widely used in therapy but its storage time is very limited due to the rapid 
deterioration of hematopoietic progenitors during liquid storage; WB can be stored refrigerated 
between 48-72 hours. Hence, de Kreuk et al. proposed a method for the preservation of whole 
blood in an automated closed hollow-fibre bioreactor system. The group developed an infusible-
grade solution for liquid storage of WB for up to 7 days (166, 167) and was successful in 
maintaining unprocessed WB in a plasma filtration system without significant cell loss (168). 
Housler et al. demonstrated a 100- and 440-fold expansion of total cells and differentiation 
towards the RBC lineage after seven days of culture in a small-scale (2 ml) and larger scale (8 
ml) compartment bioreactor (hollow-fibre system), respectively (169). The group then used a 
semicontinuous production process to produce a total cell expansion of approximately 15,000-
fold over a culture period of 19 days (169). 
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2.7.6 Other 
Jelinek et al. developed four novel bioreactors for the cultivation of hematopoietic cells: two for 
suspension cultures (a stirred system for stroma-free suspension culture, and a small-scale 
spinner flask), and two for immobilized co-culture (a fixed bed bioreactor for immobilized co-
culture of stromal and hematopoietic cells on porous microcarriers, and a miniaturized loop 
reactor) (Figure XX) (115). Both production systems portrayed in this study encompass a process 
control and cultivation was initiated with an inoculum of low cell density. The screening systems 
however did not have parameter control. The group utilised these reactors for the cultivation of 
cell lines and primary cells; they were successful in achieving an 18-fold expansion of MNCs 
and an 8-fold expansion of CFCs over a 7-day cultivation in suspension cultures. In the fixed-bed 
reactor, CB cells were cultivated in co-culture with a murine cell line for 14 days with 
supplementation of cytokines. In this system, the group attained a 100-fold expansion of MNCs 
and a 114-fold expansion of CFU-GM (progenitor cells) (115).  
 
Figure  2.3: The novel bioreactors for the cultivation of hematopoietic cells (115). 
Luni et al. developed an array of bioreactors at the microlitre scale (controlled buoyancy-driven 
thermoconvection stirring inside wells of standard 96-well plates) for the cultivation of hHSCs. 
Human UC-BD CD34
+
 cells were cultured for 7 days at five varying stirring conditions and were 
then characterized in terms of proliferation, viability, and CD34
+
 expression to verify the 
biocompatibility of the system. Numerical simulations and a 3D model were developed to 
investigate the temperature and the buoyancy-driven thermoconvection flow in the wells (170). 
Luni et al. then went on to develop a stirred multi-well bioreactor for the expansion of CD34
+
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UCB cells in hypoxic conditions. The group investigated the dependency of the expression of 
stem cell markers in CD34
+
 cells on O2 levels. They found that hypoxic conditions allowed the 
CD34
+
 cells to maintain higher expression of the stem cell marker c-kit (171). 
Timmins et al. achieved an expansion of approximately 10
7
-fold over a culture period of 21 days 
using a controlled wave agitated bioreactor system. The group was capable of producing over 
500 units of RBCs per UCB donation using fully defined culture medium (172).  
In more recent work, Csaszar et al. developed a microbead-based process control system for the 
monitoring and control of endogenously produced signalling factors (173). The latter was 
incorporated into a fed-batch bioreactor and enhanced progenitor cell outputs from human CB 
stem cell cultures were facilitated. The group revealed enhanced ex vivo proliferation of 
hematopoietic progenitor cells at higher input cell densities and over longer periods of culture 
(173). 
2.8 Commercially Available HSC Expansion Systems and Patents 
It is beyond the scope of this review to cover all commercially available bioreactor systems and 
impractical to cover all patents describing 3D HSC expansion in bioreactor systems. Hence, only 
a few commercially available systems and selected patents which have specifically focused on 
HSC-proliferation within the time period of 2000 to 2015 will be presented. Table 2.5 briefly 
describes the relevant patents. Expansion bioreactor systems have been reviewed in the literature 
elsewhere (174). 
2.8.1 Cytomatrix 
Cytomatrix very recently developed the commercial-scale manufacture of HSCs. Their 
technology includes a bioreactor solution within a closed bioreactor system, a 3D scaffold, short 
nanofibres technology, and niche factors including Ficolin and Delta-1 ligand (Figure XX). The 
theory behind the Cytomatrix is to use blood left in the umbilical cord and placenta after birth 
(which is abundant in HSCs) for BMT. The novelty of this system is that it produces more stem 
cells, in contrast to conventional laboratory techniques which produce mature blood cells (175). 
In order to expand HSCs in higher stem cells counts, the HSC-niche, which naturally occurs in 
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the human body, must be replicated. The Cytomatrix replicates this niche for successful HSC-
expansion via the bioreactor, 3D scaffold, short nanofibres and factors (175).  
 
Figure ‎2.4: Commercially available bioreactor, Cytomatrix (175). 
2.8.2 Rotary Cell Culture Systems (RCCS) – Synthecon 
The RCCS is a 3D culture system for culturing suspension and anchorage-dependant cells. Its 
unique features include its ability to co-culture cells while concurrently maintaining low shear 
force and high mass transfer of nutrients. This system can be used for stem cell maintenance, 
expansion, differentiation, tissue engineering, and more (176). 
2.8.3 Micro-Matrix – Applikon 
The micro-Matrix combines traditional stirred tank bioreactors and typical plate/flask systems. It 
is an array of fully-controlled and stirred bioreactors (24 bioreactors) at the millilitre scale. This 
down-scaled system offers control of several parameters (pH, temperature, dO2, gas/medium 
feeding) (177). 
Table  2.5: List of selected patents related to HSC proliferation in 3D bioreactors (2000 – 2015). 
Title of Patent and Brief Description 
Patent Number/ 
Publication Year 
Reference 
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Bioreactor for mammalian cell growth and maintenance 
 Bioreactor for the ex vivo expansion of normal mammalian 
cells, especially the maintenance and selective growth of 
human stem and/or hematopoietic cells. 
 Bioreactor includes a disposable, self-contained cell 
cassette, a system manager, an incubator unit and a 
processor unit.  
 The cell cassette includes a substantially circular cell 
growth chamber defined between a substantially planar cell 
bed and a gas permeable, liquid impervious membrane.  
 
US6048721A 
2000 
(178) 
Bioreactor  
 Bioreactor is comprised of three carrier plates, two 
partition wall elements with membranes configured 
permeable to nutrient medium and impermeable organic 
material being cultivated 
 Of particular interest in this is the multiplication of 
hematopoietic parent cells  
US6844187B1 
2005 
(179) 
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Continuous filling automatic cell culture system  
 Different cell types are simultaneously cultured while the 
nutrient solution and growth factor levels remain within an 
appropriate range, and unwanted metabolites are removed  
 The system allows variable perfusion rates and 
encompasses breathable, waterproof, semi-permeable 
membranes 
 
CN1740314A 
2006 
(180) 
Automatic cell culturing system  
 Fully closed bioreactor system with automated: perfusion, 
feeding, metabolite removal, and cell harvest 
CN2923716Y 
2007 
(181) 
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Automatic candidate steam cell culturing system  
 Cell culture system especially designed for in vitro 
expansion of human stem cells and/or human HSCs 
 Nutrient composition is automatically controlled and 
adjusted within the culture media to suit the cell 
requirements  
 The system also has an auto-excretion structure for 
metabolized products 
 
CN2923715Y 
2007 
(182) 
Devices and methods for growing human cells  
 A bioreactor comprised of a reaction chamber, cell 
inoculation inlet, ports for: gas exchange, filter, medium 
US20070196911A1 
2007 
(183) 
 55 
 
inlet, cell sampling, cell harvest 
Method and device for perfusion and culture of hematopoietic cell 
 A stirred bioreactor and culture chamber linked by a 
pipeline 
 Cells are first grown to high densities in the culture 
chamber and then transferred to the stirred suspension 
vessel 
 
CN1297659C 
2007 
(184) 
Bioreactor System for Culturing Hematopoiesis Cell in Vitro 
 Bioreactor system for external culture of the candidate cell 
 Includes a material make-up bottle, a gas mixture device, 
and a tubular reactor with rectangular sectional area, 
wherein the lower place of a side of the tubular reactor is 
equipped with the liquid inlet, the upper place of the other 
side is equipped with the liquid outlet, the upper bottom 
surface of a side near the liquid inlet is equipped with 
inoculating inlet, the lower surface in the reactor is 
equipped with rib, the gas mixture device is connected with 
the material make-up bottle by the pipe, the liquid inlet is 
communicated with the liquid outlet by the pipe and the 
CN101130745A/B 
2008/2012 
 
(185) 
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material make-up bottle.  
 
Novel biology reactor 
 A bioreactor comprised of a controlling box, a container 
and a magnetic stirrer; inlets for feeding, DO, pH and a 
discharge outlet. 
 HSCs can be increased by more than 50 times in expansion 
mode within two weeks 
 
CN202730134U 
2013 
(186) 
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2.9 Literature Conclusions  
The utmost challenge we as researchers are still facing in biomolecular science is accurately 
defining the microenvironment within BM niches in terms of: gas composition (specifically 
CO2), 3D structure, pressure, temperature, nutrient availability, and so on. Above all, an evident 
gap in the literature exists in terms of the precise role CO2 plays on the cellular level. Clearly, 
optimal cellular functions are not possible in the absence of CO2, i.e. it is just as indispensible as 
O2; nevertheless we are yet to pinpoint its exact purpose. The literature only vaguely describes a 
correlation between CO2 and the apoptosis cascade, and no mention is given to this gas’ direct 
role in the proliferation of any cell type (stem cells, adult stem cells, mature cells). Hence, the 
next section of this thesis will describe our work towards this goal. Our aim was to better 
understand the role and the significance of CO2 on the proliferation and death of human HSCs in 
vivo within the BM from our in vitro studies. We investigated the effects of hypo- and 
hypercapnia on human promyeloblasts in both 2D and 3D culture systems. In the above literature 
review, we have analysed in great detail the current standing of the literature on uncontrolled and 
controlled HSC-proliferation in 3D bioreactor culture systems. Considerable progress has been 
made on developing a successful bioreactor system for the ex vivo expansion of HSCs, but it is 
still in its infancy, and papers discussing the model-based control and optimization of such 
systems are very scarce. In this project, and based on the literature findings presented above, we 
have designed an individual 3D stirred suspension bioreactor. All aspects of our design are 
presented in Chapter 3.10. 
The majority of attempts made to expand HSCs ex vivo for in vivo engraftment in patients have 
been unsuccessful due to generation of inadequate cell counts or improper differentiation of the 
starting cell population (187). HSC cultivation is a rapidly developing area in both research and 
medicine in regards to the numerous applications this technology can potentially offer. However, 
the development of many potential therapeutic applications is hindered again by the limited 
availability of HSCs, and also by our narrow understanding of the BM microenvironment, 
particularly regarding CO2. Alongside the possible clinical applications of ex vivo HSC-
expansion systems, other potential applications also exist. For example, these model-systems 
could be used as platforms for pharmaceutical drug screenings and tissue engineering, or as 
models for fundamental hematopoiesis research (188). With time, hematopoiesis is becoming 
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more and more understood, particularly over the past decade, thus allowing researchers to build 
and develop systems that are close reproductions of the in vivo microenvironment.  
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3. Chapter 3: Materials and 
Methods 
In view of the literature reviewed above, we intended to explore the effect of CO2,hypo- and 
hypercapnia (decreased and increased levels of CO2, respectively) on human promyeloblasts, 
while concurrently investigating the significance of the nature of the culture system itself (2D 
versus 3D). Broadly, two experiments were conducted and are summarised below in Table 3.1. 
Table  3.1: Summary of experiments conducted. 
 Experiment 1 Experiment 2 
Cell line KG-1a KG-1a 
Hypocapnia/Hypercapnia 1% CO2/15% CO2 in air 
0.5% CO2, 21% O2, 78.5% N2 
15% CO2, 21% O2, 64% N2  
Control 5% CO2 in air 5% CO2. 21% O2, 74% N2  
Culture System 2D flasks 3D stirred suspension bioreactor 
Gases Controlled CO2 CO2, O2, N2 
Average Starting Cell 
Concentration
* 
2.00  105 cells/ml, 3.00  105 
cells/ml, 4.00  105 cells/ml 4.98  105  3.24  104 
Cell Count   
Morphology (size)   
Morphology (surface 
  
 60 
 
antigens) 
Apoptotic Profile   
Metabolism   
pH   
PDT   
% SA   
*In Experiment 1, the effect of the starting cell concentration was also examined.  
PDT: Population doubling time; % SA: % Specific apoptosis. 
Materials, methods, and apparatus used in both experiments will be presented in the following 
sections in detail. 
3.1 Cell Line – Why KG-1a? 
Table  3.2: Properties of KG-1a cells. 
Parameter Value Reference 
Temperature 37  0.5 oC 
(189-191) 
Media* 
IMDM with 10% FBS 
or  
RPMI-1640  
pH 7.4 
(192) pCO2 0.3 mmHg 
pO2 159 mmHg 
O2 specific uptake 4.0x10
-17
 mole/cell/hour (189, 190) 
Doubling time 30 hours (190, 191) 
Cell Diameter 6-14 μm  (190)  
*IMDM supplemented with 10% FBS was used in this work 
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KG-1a cells belong to the human acute myelogenous leukaemia cell line that was blocked at a 
certain stage during their maturation. Thus they are very young myeloblasts (promyeloblasts). 
They are completely resistant to teleocidins and to tumour-promoting phorbol diesters (193). 
Furthermore, this cell line is immortal and only requires straightforward standard tissue culture 
techniques. KG-1a cells grow in suspension and thus it has been well established that their 
culturing does not involve cell removal from TCP-flask-surfaces (190, 191); this is also 
advantageous for their culturing in the stirred suspension bioreactor.  
The KG-1a cells used in this experiment were donated by the Save Sight Institute of Sydney Eye 
Hospital. Optimal KG-1a culturing is achieved under the following conditions (Table 3.2): 
Also, the KG-1a cell-doubling time is about 30 hours, which is relatively stable and short. In 
suspension, the KG-1a cells appear spherical in shape, with diameters ranging from 6-14 μm.  
The KG-1a cell line was chosen as a model for human HSCs in this project. The reasons being: 
 Both KG-1a cells and human HSCs express the CD34+ antigen which is a characteristic 
feature of hematopoietic stem and progenitor cells 
 Both are non-adherent and spherical in shape 
 Both KG-1a cells and human HSCs have relatively low doubling times (30 and 48 hours, 
respectively) (194)  
 Both can be maintained in IMDM with 10% FBS  
 Both are cultured at 37  0.5 oC 
 Most importantly, in the literature, the vast majority of work describes the proliferation of 
both these cells using 5% CO2 in air, hence the novelty of our work which uses CO2 
concentrations higher and lower than this 5%.  
Hence, in view of these above analogous properties between KG-1a cells and human HSCs, we 
firmly believe our chosen cell line provides a decent model for our system’s future application to 
leukaemia.  
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3.1.1 Significance of CD34+ as a Cell Viability Marker 
Over the years, numerous studies concerning the culturing, proliferation, and/or the 
differentiation of HSCs involve the detection/analysis of the cell surface marker – the CD34+ 
antigen. This antigen is a distinctive mark of presence and viability of human hematopoietic stem 
and progenitor cells (195). CD34
+
 is a a transmembrane glycoprotein and is classified as a 
sialomucin (adhesion molecule) (195). One of the main roles of the CD34
+ 
antigen is the 
regulation of the adhesion of HSCs to the stroma (196).  
Since both KG-1a cells and human HSCs express the CD34
+ 
antigen, we have chosen to analyse 
the presence and integrity of the CD34
+
 antigen on the surface of the KG-1a cells using flow 
cytometry (details below in Section 3.9.3).  
3.2 Cell Handling 
During cell culture/passage and cultivation, a number of potential hazards are present. The 
system itself may become contaminated or the culture can pose the risk of becoming a significant 
biological hazard (depending on the cultured species). Hence, all culture components were sterile 
and free of microorganisms (bacteria and fungi). This was achieved through the sterilization of 
all equipment via autoclaving. During cell culture, the flask/vessel must was tightly sealed with 
appropriate gas inlets and outlets (0.3m filters were used for the bioreactor inlet/outlet). All cell 
handling/transfer was carried out within a laminar flow hood. 
3.3 Cell Culture and Cryopreservation 
KG-1a cells were cultured in Iscove’s Modiﬁed Dulbecco’s Medium (IMDM) supplemented 
with 4mM stable L-alanyl-glutamine (GlutaMAX
TM
, Gibco), 10% FBS (Lonza) and 5 ml Pen-
Strep (100 U/ml penicillin and 100 µg/ml streptomycin) (Sigma Aldrich), to constitute the 
complete medium. Cells were cryopreserved with complete medium supplemented with 10% 
DMSO (Sigma Aldrich) and were rapidly thawed, washed twice with fresh media, and plated in 
standard tissue culture flasks (Sigma Aldrich). The KG-1a cells were regularly maintained and 
passaged twice weekly before the initiation of the experiment. In experiment 1 (2D analysis) the 
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utilised KG-1a cells were between passage 11 and 12, and in experiment 2 (3D analysis) they 
were between passages 13 and 15. 
3.4 Culture Conditions 
3.4.1 Two-dimensional Assay 
To establish the hypo- and hypercapnia environments (1% and 15%, respectively) and the 5% 
standard environment in Experiment 1, the incubators’ CO2 levels were reprogrammed 24 hours 
prior to the commencement of the experiment [(i) Binder, CB series; (ii) Sanyo, 18AIC; (iii) 
Sanyo, 17AIC]. The cells were then maintained for 4 passages at the designated CO2 levels, 
where the 5% CO2 was the control. Upon beginning the experimentation, cells were incubated in 
each incubator in triplicate at three different starting cell concentrations (2-, 3-, and 4  105 
cells/ml) in a total volume of 8 ml. The media was not changed throughout the culture period. 
Equal samples were taken from all flasks daily for 10 days (0, 24, 48, 72, 96, 120, 144, 168, 192, 
216, and 240 hours) and cells were analysed for live cell count, cell size, morphological 
appearance, counts of cell number and viability using a cell counter (TC10

, Bio-Rad), and cell 
apoptosis using FCM (FACSCalibur

, BD Biosciences).  
3.4.2 Three-dimensional Assay 
To establish the hypo- and hypercapnia environments (0.5% and 15%, respectively) and the 5% 
standard environment in Experiment 2, the bioreactor CO2 levels were adjusted 24 hours prior to 
the commencement of the experiment. Antifoam C (AFC) has virtually no effect on cell 
proliferation and differentiation (197). In these experiments, an AFC content of 0.0125% was 
used and resulted in a foam-free process in the bioreactor system during the sparging of air. To 
allow maximized homogenous mixing, with minimal shear stress, a floating stirrer bar was used. 
Sparging of air is necessary to ensure adequate concentrations of all gases for cell expansion. 
This was done by means of a custom made dispersion ring. Pumping of air was regulated by 
means of gas flow controllers and regulators. 
Upon beginning the experimentation, cells were incubated in the bioreactor at an average starting 
cell concentration of 4.98  105  3.24  104 cells/ml in a total volume of 250 ml. The media was 
not changed throughout the culture period. Equal samples were taken from the bioreactor in 
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triplicate daily for 11 days (at 0, 24, 46, 70, 94, 125, 144, 166, 190, 214, 238 hours); bioreactor 
medium level was not controlled since only a minute sample was withdrawn daily. The cells 
were then analysed for: viability and cell size using a cell counter (TC10

, Bio-Rad), cell 
apoptosis using FCM (FACSCalibur

, BD Biosciences), and cell surface antigens using FCM 
(FACSDivam LSRFortessa X-20, BD Biosciences). DO, CO2, pH, and temperature were also 
recorded throughout the experiment every 17 minutes. 
3.5 Cell Morphology, Proliferation and Population Doubling Time 
After exposure to varying CO2 levels, the morphological modifications in the KG-1a stem cells 
were examined after 0, 72, 96, and 168 hours using Olympus CKX31/41 Fluorescence Inverted 
Microscope with ProRes C5 Camera. Cells were analysed for cell count and cell size using 
TC10

 (BioRad). A 10 l sample of cells was mixed with 10 l trypan blue (BioRad, 145-0021); 
mixture was loaded onto a slide and automatically analysed. In order to compare rates of cell 
proliferation at the varying CO2 levels (1, 5, and 15) %, the population doubling time (PDT) was 
calculated using the following equation: 
31.3)/log( 

NoN
t
PDT
     Equation 2: Population doubling time 
Where t is time, N is cell concentration at time t, and N0 is cell concentration at t = 0 (82). 
When cells reached their maximum confluency, cell concentration was validated and compared 
to initial seeding concentration at time zero.  
3.6 Glucose Depletion 
Cell medium was analysed for glucose content (g/l) using a bioanalyser (YSI Bioanalyzer 2700, 
YSI Life Sciences). Samples were prepared as per instrument instruction manual and analysed 
after system calibration using glucose standard.  
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3.7 pH 
pH was continuously measured (online) during the 3D experiment using a pH sensor (Applikon) 
and recorded every 17 minutes using LabView software. 
3.8 Statistical Analysis 
Results are expressed as the mean of three independent experiments (2D) or three independent 
samples from the culture medium (3D). Error bars in all figures represent the standard deviation. 
Statistical significance was determined by the Student’s t-test for two-tailed distributions, 
assuming equal variances for both samples using Excel software (Microsoft Corporation). 
Probability values less than 0.05 were considered statistically significant. 
3.9 Flow Cytometry Analysis 
Many techniques are crucial for the counting and/or characterization of stem cells (e.g. grid 
cytometry, microscope imaging, FCM). However, it is beyond the scope of this document to 
provide a detailed description and review of each technique. This project will focus on cell 
analysis via the use of FCM and TC10 automated cell counter. 
Flow cytometers are now not only utilised for research in laboratories, but they are also an 
essential technique in the clinical field; they have become indispensable tools in both clinical and 
biomedical fields (198, 199). They have numerous applications; these include all forms of cell 
biology, immunology, genetics, cross-examination of cell membranes, cytoplasmic and nuclear 
antigens, as well as the interrogation of cells, either as a whole or on the scale of cellular 
constituents (organelles, nuclei, DNA/RNA, chromosomes, hormones, proteins, etc…) using 
appropriate probes (198-200).  
Also, FCMs are used nowadays for cell and chromosome sorting, single cell molecular 
characterization, propagation of HSCs, and purification of cells and cell fragments (Table 9) 
(199). In terms of cells biology, viable cells are functional cells and are capable of reproducing 
(199). FCMs also determine viability based on membrane integrity – certain dyes only stain dead 
cells, thus unstained cells are deemed viable (199).  
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In this study, FCM was used to determine the apoptotic capacity of the KG-1a cells and also their 
cell-surface antigen (CD34
+
) profile. 
3.9.1 Apoptosis 
Cells were analysed for apoptotic capacity using FCM (FACSCalibur

, BD Biosciences). Cells 
were prepared prior to analysis using a FITC Annexin V Detection Kit with PI (BioLegend) as 
per manufacturer’s instructions. Briefly, cell samples were washed twice with Cell Staining 
Buffer and then resuspended in Annexin V Binding Buffer before being treated with FITC 
Annexin V and PI solutions. Cells were then gently vortexed and incubated for 15 minutes at 
room temperature in the dark before FCM analysis. FlowJoX 10.0.7r2 software was then used 
for data analysis. The gating strategy used was as follows: all events were first displayed using 
Annexin V versus PI. Then a region around the double negative fraction was drawn, which was 
then displayed using FSC versus SSC plot. Then a tight region around the subset of cells with 
low FSC was created (debris). The debris gate was then inverted creating a non-debris gate, 
which was used on the original/total population. Finally a new plot using Annexin V versus PI 
was used to display ‘all cells without debris’. 
3.9.2 Specific Apoptosis 
Specific Apoptosis (SA) was calculated as previously described (201) using the following 
formula: 
Ac
AcAe
SA



100
100(%)
     Equation 3: Specific Apoptosis 
Where Ae is percentage of apoptotic cells in the experimental population and Ac is percentage of 
apoptotic cells in the control population.  
The lower the % SA of the experimental cells, the lower the apoptotic capacity with respect to 
the control population.  
3.9.3 Cell-Surface Antigen Profile 
Cells were also analysed for surface antigen integrity using FCM (FACSDivam LSRFortessa X-
20, BD Biosciences). Cells were prepared prior to analysis using a cocktail of four fluorochrome-
conjugated primary antibodies and corresponding isotype controls (Human Hematopoietic 
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Progenitor Cell Multi-Colour Flow Kit, R&D Systems). Briefly, cell samples were first 
suspended in staining buffer and then incubated with fluorochrome-conjugated antibodies or 
isotype controls for 30 minutes. The cells were then washed and resuspended in staining buffer 
before being analysed by FCM. FlowJoX 10.0.7r2 software was then used for data analysis.  
3.10 Bioreactor System 
The 3D culture system is composed of three distinct subunits which are a) bioreactor, b) 
monitoring and control circuit, c) feeding circuit.  
3.10.1 Bioreactor  
Following the extensive literature review on bioreactors and bioreactor applications to HSCs 
(Sections 2.3 and 2.4), the stirred suspension-type bioreactor was chosen due to its many 
advantages over others [62]. This bioreactor provides a homogenous environment for the cells to 
grow in which means equal distribution of gases, nutrients, and pH for optimal cell proliferation.  
The bioreactor used in this research was specially designed and custom made by Custom-Blown 
Glassware Pty Ltd (Sydney, Australia) to suit the needs of our project. The related review above 
was also used to design all aspects of our vessel. The stirred suspension bioreactor is appropriate 
for our cell line which grows in suspension, not on surfaces. For warming the cell culture, a 
water jacket was incorporated into the design. For ease of monitoring, several ports were 
included into the vessel lid for sensor probes. Also, the size was large enough to obtain a 
satisfactory amount of cells and to allow for the immersion of both a gas dispersion ring and 
floating magnetic stirrer bar, but also small enough to be performed on the bench top without 
posing any significant hazards. Most importantly, and in light of our elaborate literature review 
on CO2 above, the bioreactor was manufactured to support the influx of gases (O2, CO2, and N2) 
via the gas dispersion ring.  
Initially, the rough sketch below (Figure 3.1) was proposed. 
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Figure  3.1: First sketch of the bioreactor design. 
This was followed by the manufacture of a sample bioreactor at a smaller scale (Figure 3.2): 
 
Figure  3.2: Small scale sample bioreactor. 
The final product is shown in the following figure (Figure 3.3):  
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Figure  3.3: Final bioreactor manufactured and used in experimental. 
3.10.2 Monitoring and Control Circuit 
This was composed of:  
- DO sensor  
- CO2 sensors (dissolved and headspace) 
- Temperature sensor 
- pH sensor 
- Data acquisition: Software program (LabView) 
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3.10.3 Feeding Circuit 
This was composed of:  
- Gas flow controllers (1  20 sccm (CO2), 1  100 sccm (O2), 1  200 sccm (N2)) 
- Gas cylinders and regulators with suitable stainless steel piping   
- Water chiller (set to 37 oC) 
- Floating magnetic stirrer  
- Gas sparger (specially designed and manufactured – stainless steel ring with 1 mm pores) 
3.11 Experimental Setup  
A schematic diagram of the experimental system is shown in the figure below (Figure 3.4), while 
table 3.3 summarises the system configurations. 
 
Figure  3.4: Schematic diagram of the stirred suspension bioreactor system 
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Table  3.3: Bioreactor System Configurations. 
Vessel Vessel Height 145 mm 
 Vessel Diameter 13 mm 
 Total Volume 750 ml 
 Working Volume 250 ml 
 Liquid Height 80 mm 
   
Ports 3  diameter 12 mm 
 1  diameter 8 mm 
 3  diameter 6 mm 
   
Stirrer Bar Floating magnetic stirrer 
54  28 mm 
22-2631-01, Taylor Scientific 
   
Sparger (stainless steel ring) Ring Diameter  100 mm 
 Orifice Diameter 1 mm 
   
Sensors pH Applikon 
 DO Real Time Engineering 
 dCO2 Real Time Engineering 
 CO2 PASPORT (PS-2110) 
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Flow Controllers O2 
MC-200SCCM-D  
(Alicat via Duff and 
Macintosh PTY. LTD.) 
 CO2 
MC-20SCCM-D  
(Alicat via Duff and 
Macintosh PTY. LTD.) 
 N2 
MC-100SCCM-D  
(Alicat via Duff and 
Macintosh PTY. LTD.) 
   
Software 1 LabView Version (2008) 
   
Software 2 Flow Vision SC Software 
Alicat (via Duff and 
Macintosh PTY. LTD.) 
Software 3 PASCO Capstone PASCO (UI-5401) 
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4. Chapter 4: Experimental 
Results 
4.1 Introduction 
Growing and culturing HSCs and other progenitor cells in scalable quantities is potentially a 
huge advantage for both research and therapy. However, researchers must first determine ideal 
parameters that offer these cells an optimal culture environment in vitro prior to any clinical use. 
A typical HSC-culture system must encompass stable and well-adjusted physiological and 
chemical properties, such as: pH, temperature, osmolality, proteins, growth factors, and O2 and 
CO2 concentrations so as to overall mimic the physiological in vivo environment of the cells. 
This would hence ensure optimal proliferation and maintenance of the cell population in vitro.  
In view of the literature presented throughout this thesis thus far, we intended to explore the 
influence of varying CO2 concentrations (1, 5, and 15%) in air on promyeloblast KG-1a cells 
using standard 2D cell-culture techniques. The CO2 concentrations exploited herein were 
arbitrarily chosen and not optimised experimentally, yet derived from a physiological logic. Our 
hypothesis is that, similarly to O2, CO2 also participates in key role(s) within the BM progenitor 
cells niches. Is it possible that either hypo- or hypercapnia is favoured for optimal progenitor 
cells’ (such as HSCs) proliferation? Does CO2 directly affect the expansion of KG-1a cells? We 
established that lowered CO2 levels increase proliferation rate, but reduce overall cell expansion, 
while also and accelerating apoptosis; on the contrary, elevated CO2 levels decrease proliferation 
rate, and increase overall cell expansion while delaying cell apoptosis, in comparison to the 
standard 5% CO2 control.  
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4.2 Experiment 1 - Hypercapnia Slows Down Proliferation and Apoptosis of 
Human BM Promyeloblasts  
4.2.1 Cell Morphology 
The cell morphology of KG-1a cells was examined with respect to shape and size. The shape of 
the cells was inspected by means of an inverted microscope at 0, 72, 96, and 168 hours, 
respectively. The latter revealed only slight differences between the varying CO2 culture 
conditions, but the cells retained their myeloblast appearance (Figure 4.1) and only decreased 
slightly in size with an increase in confluency. This was then validated by cell size quantification 
(Figure 4.2) where all cultures showed very similar patterns in cell size. At the initiation of the 
experiment, cell size was 10.56  0.59 m across all populations. Then at 96 and 192 hours, it 
was 8.56  0.09 m and 8.33  0.16 m, respectively (Table 4.1). This trend was also observed 
in the FCM analysis. 
1% CO2 
    
5% CO2 
    
15% CO2 
    
 0 hours 72 hours 96 hours 168 hours 
Figure  4.1: ProRes C5 images of KG-1a cells using Olympus CKX31/41 inverted microscope 
(40 times magnification) at 0, 72, 96, and 168 hours. 
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Figure  4.2: KG-1a cells’ size in m (y-axis) that were cultured at 1% (A), 5% (B) and 15% (C) 
CO2 over time in hours (x-axis) at three different starting cell concentrations ( 2.00  10
5
 
cells/ml, 3.00  105 cells/ml, 4.00  105 cells/ml). At time = 240 hours, cells cultured at 
(1 and 5) % CO2 were dead and hence cell size is zero. Each time point represents average of 
three independent experiments ± standard deviation. 
Table  4.1: Average cell size of KG-1a cells at varying CO2 concentrations with time.  
Time (Hours) 
Cell Size (μm) 
1% CO2 5% CO2 15% CO2 
0 10.44  1.26 10.89  0.19 10.33  1.15 
96 8.78  0.19 8.67  0.33 8.22  0.38 
192 8.56  0.19 8.33  0.33 8.11  0.51 
*Results are expressed as the mean of three independent experiments ± standard deviation. 
4.2.2 Average Cell Population Doubling Time (PDT) and Cell Proliferation 
Table 4.2 below displays the average PDT and viability of KG-1a cells grown at (1, 5, and 15) % 
CO2 in air at three different starting cell concentrations. Analysis of these values showed that 
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KG-1a cells cultured at 5% and 15% had an average PDT of 1.22  0.11 and 1.51  0.17 times 
higher than that of cells cultured at 1% CO2, respectively (Table 4.2). This indicated that cells 
cultured at 1% CO2 proliferated at a faster rate. Average cell PDT also increased with an increase 
in initial cell concentration (Table 4.2). 
Table  4.2: Average population doubling time (PDT) and viability of KG-1a cells grown at (1, 5, 
and 15) % CO2 in air at three different starting cell concentrations. 
Average Starting Cell 
Concentration 
(cells/ml) 
CO2 (%) 
Average PDT 
(hours) 
Average Viability 
(%) 
(2.06E+05)  (9.23E+04) 1 21.36 95  0.03 
(1.99E+05)  (1.44E+04) 5 28.61 97  0.01 
(2.02E+05)  (1.38E+04) 15 33.61 97  0.02 
(3.22E+05)  (2.02E+05) 1 25.67 95  0.02 
(3.24E+05)  (6.12E+04) 5 28.64 96  0.02 
(3.01E+05)  (8.21E+04) 15 33.85 96  0.02 
(4.05E+05)  (4.04E+04) 1 27.02 95  0.01 
(3.93E+05)  (5.51E+03) 5 32.41 97  0.02 
(4.13E+05)  (1.50E+04) 15 44.45 97  0.01 
*Starting cell concentration and viability are an average of three independent experiments ± 
standard deviation 
In exploring the effect of hypo- and hypercapnia on KG-1a cell proliferation, it can be seen that 
cells grown in hypercapnia (15% CO2) reached maximum cell concentrations 1.39  0.22 and 
1.06  0.08 times higher than cells cultured at 1% and 5% CO2, respectively (Figure 6.3). Also, 
and in parallel to the average PDT data, cells cultured in hypercapnia proliferated slower and 
reached their maximum cell concentration after 168 hours, in contrast to the cells cultured at 1% 
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and 5% which reached their maximum cell numbers prior to 168 hours. In summary, cells grown 
in hypocapnia proliferated faster and but also underwent apoptosis faster, whereas cells grown in 
hypercapnia proliferated and reached higher cell numbers slower with time, but also underwent 
apoptosis slower. Moreover, and analogous to the average PDT figures, it can be seen that 
proliferation in each culture increases with an increase in initial cell concentration (Figure 4.3). 
This trend can also be seen in the microscope images (Figure 4.1) where cells cultured at 1 and 5 
% CO2 reached much lower levels of confluency in contrast to those cultured at 15% CO2. 
 
Figure  4.3: Proliferation curves of KG-1a cells cultured at CO2 concentrations of 1% (A), 5% (B) 
and 15% (C) CO2 over time, where y-axis and x-axis show cell concentration (cells/ml) and time 
(hours), respectively,  each at three different starting cell concentrations ( 2.00  105 cells/ml, 
3.00  105 cells/ml, 4.00  105 cells/ml). Each time point represents three independent 
experiments ± standard deviation. 
4.2.3 Cell Apoptotic Profile  
FCM data of the KG-1a cells at 96 and 192 hours confirmed the proliferation studies (Figure 4.4) 
in that cells grown in hypercapnia undergo apoptosis much later during the batch-culture period 
in contrast to cells grown in hypocapnia and control conditions. The percentage of live cells 
(Figure 4.4 A) is significantly (0.0252) higher for cells grown in hypercapnia at 192 hours. Also, 
cells grown in hypocapnia are more apoptotic at 96 hours in comparison to cells grown at 5% 
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and 15% CO2 (Figure 4.4 B). Once again, with an increase in initial cell concentration within 
each culture group, there is a decrease in PDT, and hence a decrease in the rate of undergoing 
apoptosis. Also, the % SA of the hypocapnic cells is higher than that of the hypercapnic cells at 
both 96 and 192 hours (Table 4.3).  
 
Figure  4.4: Flow cytometry analysis of FITC Annexin V (x-axis) and propidium iodide (PI) (y-
axis) staining showing high CO2 concentration preserves KG-1a cells from early apoptosis and 
delays cell death. KG-1a cells were cultured at three CO2 levels [1% (top row), 5% (middle row) 
and 15% (bottom row)]. Two representative time points (96 hours (left) and 192 hours (right)) 
were selected to show the pattern. The quadrants in each blot show percentages of KG-1a that 
are alive (Q4), early apoptotic (Q3), late apoptotic (Q2) or necrotic cells (Q1). 
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Table  4.3: Specific apoptosis (SA) of hypo- and hypercapnic populations (calculated in 
comparison to 5% CO2 control populations) at three different starting cell 
concentrations. 
Average Starting Cell 
Concentration 
(cells/ml) 
CO2 (%) 
SA (%) 
96 hours 192 hours 
(2.06E+05)  (9.23E+04) 1 2.27 0.37 
(2.02E+05)  (1.38E+04) 15 0.87 -0.06 
(3.22E+05)  (2.02E+05) 1 -0.16 -0.34 
(3.01E+05)  (8.21E+04) 15 -0.05 -1.79 
(4.05E+05)  (4.04E+04) 1 0.36 -0.36 
(4.13E+05)  (1.50E+04) 15 -0.76 -0.01 
*Starting cell concentration is an average of three independent experiments ± standard deviation. 
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Figure  4.5: Error bar plots showing the effect of (1, 5, and 15) % CO2 concentrations on KG-1a 
cell count. The x-axis for all plots shows % CO2, while the y-axis shows in (A) % live KG-1a 
cell fraction, in (B) % early apoptotic KG-1a cell fraction, in (C) % late apoptotic KG-1a cell 
fraction, and in (D) necrotic KG-1a cell fraction. Two representative time points [96 hours (○) 
and 192 hours (□)] were selected to show the pattern. Each time point represents three numbers 
of independent experiments ± standard deviation. 
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4.3 Experiment 2 - Hypercapnia Slows Down Proliferation and Apoptosis of 
Human BM Promyeloblasts in 3D Suspension Bioreactor 
In Section 4.2, we reported that increased dissolved CO2 concentrations of 15% (hypercapnia) in 
standard 2D tissue culture flasks brought about enhanced cell proliferation with respect to the 5% 
control, as opposed to considerably decreased proliferation in hypocapnic populations (1% CO2) 
(1). We also described that hypercapnia distinctly delayed apoptosis; similarly, hypocapnia was 
shown to accelerate cell apoptosis. Herein, we intend to investigate the effect of varying CO2 
concentrations (0.5, 5, and 15) % in air on promyeloblast KG-1a cells in a 3D stirred suspension 
bioreactor. The CO2 concentrations exploited herein were arbitrarily chosen and not optimised 
experimentally, yet derived from a physiological logic. Our hypothesis is that hypercapnia slows 
down the proliferation and apoptosis of human BM promyeloblasts and 3D culture systems are 
favoured over conventional 2D methods. Will hypercapnia be optimal for progenitor cell 
proliferation (such as HSCs)? Will CO2 have any direct effects on KG-1a cell-surface antigens? 
How will the 3D culture system compare overall to the 2D one? Our results confirmed the 
outcomes from the previous experiment in that KG-1a cell-apoptosis was delayed in hypercapnic 
conditions; this was accompanied by an increase in overall cell concentration and a decrease in 
cell proliferation rate with respect to both the hypocapnic and control populations. 
4.3.1 Cell Morphology (Size) 
KG-1a cell morphology was inspected in terms of cell size by means of TC10 daily. All cultures 
showed similar size development patterns (Figure 4.6). At the initiation of the experiments, cell 
size was 13.00  0.00 m across all populations, and then at 70 and 190 hours it was 10.00  
0.00 m and 8.00  0.00 m, respectively. 
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Figure  4.6: KG-1a cells’ size in m (y-axis) that were cultured at 0.5 % ( ), 5 % ( ) and 15 
% ( C) CO2 over time in hours (x-axis). Each time point represents average of three 
independent experiments ± standard deviation. 
4.3.2 Cell Morphology (Cell-Surface Antigen Integrity) 
Cells were analysed for cell surface antigen integrity when the maximum cell concentration was 
reached: 0.5% CO2, 5.0% CO2, and 15.0% CO2 at 125, 144, and 166 hours, respectively. From 
the FCM data of the KG-1a cells (Figure 4.7), it can be seen that both the hypercapnic and 
control populations revealed comparable CD34
+
 positive staining (96.6 and 96.7%, respectively). 
On the other hand, the hypocapnic cells were only 87.9% positive for this surface antigen.  
 
Figure  4.7: Flow cytometry analysis of KG-1a cell surface antigen integrity at time of maximum 
cell concentration reached. KG-1a cells were cultured at three CO2 levels [0.5 % (left), 5 % 
 83 
 
(middle) and 15 % (right)]. The second quadrant (Q2) in each blot shows the percentage of KG-
1a cells that are CD34
+
 positive. 
4.3.3 Average Cell Population Doubling Time (PDT) and Cell Proliferation 
KG-1a cell cultures at 0.5% CO2 had an average PDT higher than that of both 5% and 15% 
cultures (46.11, 42.20, and 43.28, respectively) (Table 4.4). This indicates that cells cultured in 
hypocapnia proliferated at a much slower rate, whereas cells cultured in control conditions (5% 
CO2) expanded the fastest. 
According to cell proliferation, it can be seen from Figure 4.8 that cells cultured in hypercapnia 
reached maximum cell concentrations 2.54  0.16 and 1.03  0.26 times higher than cells 
cultured at 0.5% and 5%, respectively. However, the three different cultures reached maximum 
cell concentration at varying times: 0.5% CO2 at 125 hours, 5% CO2 at 144 hours, and 15% CO2 
at 166 hours.  
Table  4.4: Average population doubling time (PDT) and viability of KG-1a cells grown at (0.5, 
5, and 15) % CO2 in air. 
Average Starting Cell 
Concentration 
(cells/ml) 
CO2 (%) 
Average PDT 
(hours) 
Average Viability 
(%) 
(2.06E+05)  (9.23E+04) 0.5 46.11 94.67  2.89 
(1.99E+05)  (1.44E+04) 5 42.20 93.67  0.58 
(2.02E+05)  (1.38E+04) 15 43.28 93.33  1.53 
*Starting cell concentration and viability are an average of three independent experiments ± 
standard deviation. 
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Figure  4.8: Proliferation curves of KG-1a cells cultured at CO2 concentrations of 0.5 % ( ), 5 
% ( ) and 15 % ( C) CO2 over time, where y-axis and x-axis show cell concentration 
(cells/ml) and time (hours), respectively. Each time point represents three independent 
experiments ± standard deviation. 
4.3.4 Cell Apoptotic Profile  
FCM data of the KG-1a populations at 46, 125, and 190 hours (Figure 4.9) was analogous to the 
proliferation studies in that cells grown in hypocapnic conditions underwent apoptosis much 
earlier than the control and hypercapnic cells. The percentage of live cells in the hypercapnic 
cultures was higher than the control and hypocapnic cells at all three time points. Similarly, the 
percentage of apoptotic cells in the hypocapnic cultures was higher than the control and 
hypercapnic cultures at all three time points. Also, the % SA of the hypocapnic cells is higher 
than that of the hypercapnic cells at all three time points (Table 4.5). In summary, cells grown in 
hypocapnic conditions expanded much slower and reached apoptosis much faster than other 
populations, whereas hypercapnic cells proliferated at a medium rate and reached their maximum 
cell number slower with time, but also underwent apoptosis slower than all other populations.  
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Figure  4.9: Flow cytometry analysis of FITC Annexin V (x-axis) and propidium iodide (PI) (y-
axis) staining showing high CO2 concentration preserves KG-1a cells from early apoptosis and 
delays cell death. KG-1a cells were cultured at three CO2 levels [0.5 % (top row), 5 % (middle 
row) and 15 % (bottom row)]. Three representative time points (46 hours (left), 125 hours 
(middle), and 190 hours (right)) were selected to show the pattern. The quadrants in each blot 
show percentages of KG-1a that are alive (Q4), early apoptotic (Q3), late apoptotic (Q2) or 
necrotic cells (Q1). 
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Table  4.5: Specific apoptosis (SA) of hypo- and hypercapnic populations (calculated in 
comparison to 5 % CO2 control populations). 
Average Starting Cell 
Concentration 
(cells/ml) 
CO2 (%) 
SA (%) 
46 hours 125 hours 190 hours 
4.98  105  3.24  104 
0.5 3.36 4.20 5.21 
15 0.16 -0.12 -0.68 
4.3.5 Cell Metabolism and pH 
Glucose depletion studies revealed that in hypocapnia, glucose was removed from the media at a 
faster rate than in hypercapnia and control conditions. Similarly, hypercapnic populations 
metabolized glucose at a much slower rate throughout the whole experiment (Figure 4.10).  
 
Figure  4.10: Glucose depletion curves of KG-1a cells cultured at CO2 concentrations of 0.5 % 
( ), 5 % ( ) and 15 % ( C) CO2 over time, where y-axis and x-axis show glucose 
concentration (g/ml) and time (hours), respectively. Each time point represents three independent 
experiments ± standard deviation. 
Figure 4.11 confirmed that hypercapnia acidified our cell media, whereas both the control and 
hypocapnic populations had comparable pH throughout the experiment at levels somewhat 
neutral.  
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Figure  4.11: pH curves of KG-1a cells cultured at CO2 concentrations of 0.5 % ( ), 5 % 
( ) and 15 % ( C) CO2 over time, where y-axis and x-axis show pH and time (hours), 
respectively. pH was continuously measured during the experiment and recorded every 17 
minutes. 
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5. Chapter 5: Discussions – 
Hypercapnia Delays the 
Apoptosis Cascade 
5.1 Discussions 
The exploitation of in vitro expanded cells for tissue-based engineering research and therapy is a 
growing treatment modality. Each class of cells in the human body grows in a specific 
environment which provides the cell with optimal proliferation, hence all cells behave 
differently. Thus, for each cell type, the most favourable in vitro cell expansion protocol must be 
well-defined. This protocol encompasses not only culture medium composition, but also includes 
parameters such as gas concentrations, sheer force, pressure, temperature, and system nature (2D 
versus 3D) (3). The specific use of HSCs for the treatment of hematopoietic-related disorders, 
such as leukaemia (15, 38), is a continually rising field of interest. HSCs require specific culture 
conditions and parameters in order to provide them with a suitable environment to consequently 
obtain optimal proliferation. Herein, we have worked towards defining the most favourable in 
vitro cell expansion protocol for the optimal proliferation of KG-1a cells on a larger scale within 
a 3D culture system. The KG-1a cell line is a human acute myelogenous leukaemia cell line that 
was blocked during maturation. These cells are promyeloblasts and resistant to teleocidins (193). 
KG-1a cells are spherical in shape and grow in suspension which makes their culturing practical 
in 3D suspension bioreactors (190, 191). Most significantly, KG-1a cells express the CD34
+
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surface antigen similar to human HSCs, hence facilitating their use as a useful model for research 
which can be applied to human HSCs in the future.  
Of the many parameters that regulate and influence stem cell proliferation and/or differentiation, 
O2 tension is regarded the most critical and is subsequently the most explored throughout the 
literature. In cell culture, O2 tension directly affects stem cell proliferation via altering the 
production of growth factors, surface markers, transcription factors and by also interfering in the 
cellular respiratory pathways (68). The literature broadly illustrates that hypoxic conditions (low 
O2 concentrations of about 2-5%) are favoured in order to retain ESC pluripotency, while 
normoxic conditions (atmospheric O2 concentrations of about 20%) enhance the proliferation 
and expansion of mature cells (66). Stem cells can only be obtained in relatively low numbers 
and hence need to be cultured and grown into large numbers in vitro; if this cultivation were to 
be undertaken at normoxic levels, not only would the cells be triggered to differentiate (thus loss 
of pluripotency), but cell viability would also decrease as a result of oxidative stress (63). Cell 
proliferation is more likely maintained by decreased O2 levels (2-5%) so as to mimic cellular in 
vivo environment within the BM which is almost anaerobic. Nevertheless, significantly low O2 
concentrations (0-1%) have been reported to induce a state of dormancy in cell cultures and thus 
halt cell expansion (66).  
Alongside O2, CO2 in mammalian cells is also imperative but disregarded throughout the 
literature. Physiologically dissolved CO2 is generally equivalent to a Pco2 of 50-70 mmHg in 
mammalian cells at 37
o
C (202) and altering this CO2 level has been shown to have various 
effects on in vitro cultures. It was shown that high CO2 concentrations stimulated erythropoiesis 
(76), increased blastocyst development (73), regulated excitatory synaptic interactions of 
brainstem neurons (78), decreased Chinese hamster ovary cell  proliferation (77), decreased 
metabolism (50), inhibited epithelial cell (79, 80) and fibroblast proliferation (80). There is 
conflicting evidence in the literature about the effect of low CO2 concentrations.  It was shown 
that hypocapnia enhanced the expression of pluripotency and differentiation genes in mouse 
ESCs (82), but suppressed cell proliferation through NF-Kβ signalling pathway (203, 204). One 
study evaluated the proliferation of human HSCs from umbilical CB in roller bottles in a CO2-
free environment and their results showed an 18-fold expansion of total CFU in L-15 medium 
(81). 
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Within the stem cell niche, there exists a correlation between O2 consumption and CO2 
production which, in turn, may allow cells to sense changes in CO2 concentrations in parallel 
with O2. Morton (1967) hypothesized that higher levels of CO2 promote the flow of calcium into 
primitive cells of rat BM which, in turn, stimulates the cells to divide and proliferate at higher 
rates compared to cells cultured at lower CO2 levels (76). Jyoti et al. have proposed that it is 
possible that a protein exists within cells that recognizes modifications in CO2 concentrations 
(75). The up-regulation of this protein may potentially stimulate/inhibit various enzymatic 
pathways, metabolic activities, and/or membrane excitability. Since it is generally accepted in 
the literature that hypoxic conditions are favoured for HSC proliferation to mimic the cellular in 
vivo environment, could a hypo- or hypercapnic environment also be favoured for HSC 
proliferation over the typical 5%? To investigate this hypothesis, a comparative study was 
conducted to study the effect of hypocapnic (0.5-1% CO2 in air) and hypercapnic (15% CO2 in 
air) conditions on human KG-1a cells as compared to the commonly used 5% CO2 control. The 
cells were examined for their expansion rate, proliferation, apoptotic profile, metabolism, and 
morphology.  
Experiment 1 evaluated the KG-1a cell expansion in static 2D flasks at 1%, 5%, and 15% CO2 in 
air. Concurrently, at each CO2 concentration, cells were seeded at three different starting cell 
concentrations. This experiment firstly revealed that both hypo- and hypercapnia had no 
substantial effect on HSC-morphology in terms of cell shape and size as examined through an 
inverted microscope. Furthermore, hypercapnia decreased KG-1a cell proliferation rate but 
extended survival by delaying the apoptosis cascade. Cells also reached higher maximum 
concentrations in hypercapnic conditions in comparison to the 5% control and 1% hypocapnia. 
The hypocapnic populations, although had increased cell PDT, revealed decreased maximum cell 
concentration reached over time in comparison to both the control and the hypercapnic cells, as 
well as increased apoptosis rates. Hence, having cells which cycle at a slower rate would be 
favourable for sustaining survival and for mimicking the in vivo environment where it is 
established that cells proliferate at a gradual pace. According to initial cell concentration, it was 
understandably established that greater cell counts were produced with a greater starting cell 
volume. 
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Experiment 2 was an extension of our first where the same cells were seeded at elevated cell 
counts in hypo- and hypercapnic environments but in a 3D culture system. Once again, our 
experimental showed that both hypo- and hypercapnia had no considerable effect on cell 
morphology in terms of cell size. However, FCM analysis revealed that hypocapnia significantly 
decreased the expression of the CD34
+
 surface antigen, the latter being unaffected by 
hypercapnia with respect to the control populations. Hypercapnia also yielded a higher maximum 
cell concentration and lower PDT, and the contrary in the hypocapnic cell populations. 
According to apoptosis, hypercapnia clearly delayed the progress of apoptosis in the KG-1a cells 
once more and vice versa for the hypocapnic cells, confirming our results from Experiment 1. 
This is also parallel to the glucose depletion studies, where the cells that cycled slower 
(hypercapnic) metabolised glucose at a respectively slower rate and cells that cycled faster 
(hypocapnic) depleted glucose at a much faster rate from the medium. 
To justify our novel outcomes, several hypotheses were put forward based on present literature. 
Firstly, it was hypothesised that hypercapnia relatively slows down proliferation and metabolism, 
and in turn, slows down cellular stress, and thus reduces the number of gene mutations that 
would potentially occur during cell proliferation/division, hence reducing the apoptosis rate, in 
turn, yielding higher cell concentrations per millilitre. Similarly, cells cultivated in hypocapnia 
proliferated at a much faster rate, and were thus subjected to more stress, hence causing more 
irregular gene mutations, rendering a higher rate of apoptosis.  
Moreover, ROS are the main stimulators of apoptosis and are suppressed by higher levels of CO2 
(59, 61). So, our second hypothesis was that the ROS inhibition is accountable for the lower % 
SA observed in the hypercapnic populations. The acidified cell medium in the hypercapnic 
populations lead us to our third hypothesis: The apoptosis cascade is also greatly influenced by 
alterations in the mitochondrial membrane permeability (59, 71), where stability of the latter 
hinders apoptosis (59). The mitochondrial membrane has been shown to stabilise at acidic pH 
values (60), hence it can also be hypothesized that the increased CO2 levels used in this 
experiment hindered apoptosis in this way. The latter was also illustrated by Carney et al. who 
revealed that CO2 acts as a weak acid to maintain intracellular pH at relatively low levels by 
readily diffusing across the cell membrane and combining with intracellular water to form 
carbonic acid, which subsequently dissociates into HCO3
-
 and hydrogen ion and regulates the 
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intracellular pH (73). This reasoning appears genuine since similar trends have also been 
demonstrated elsewhere in the literature (59, 72).  
Moreover, CO2 is the most significant of factors that manipulate the affinity between O2 and 
haemoglobin and consequently modifying the oxyhemoglobin dissociation curve (75). This 
curve evidently shifts to the right with a subsequent increase in the Pco2 and vice versa is also 
true. This shift in the oxyhemoglobin dissociation curve, brought about by modifications in Pco2, 
is identified as the Bohr effect and is largely attributable to subsequent alterations in pH (75). 
Hence, with an increase in Pco2, the affinity between O2 and haemoglobin is decreased. Another 
hypothesis that can describe this study’s trend could be the relationship between O2, CO2, and 
haemoglobin. As mentioned above, with an increase in Pco2 there is a subsequent decrease in the 
affinity between O2 and haemoglobin and a decrease in pH. Indeed CO2 is approximately 20 
times more soluble in water than O2 and has a solubility coefficient (ks) of 0.06 ml.dl
-1
.mmHg
-1
. 
This implies that about 5% of blood CO2 exists as physiologically dissolved CO2; hence 
humidified cell incubators in cell-culture studies are typically controlled at 5% CO2 levels. CO2 
effortlessly diffuses across red blood cell membrane into the cell interior and is transported in the 
blood in three forms: 5% as dissolved CO2, 5% carbaminohemoglobin, and 90% as HCO3
-
 (205). 
The total CO2 in the plasma is proportional to the partial pressure of the gas and its solubility 
coefficient (0.03 ml/100 ml plasma for each 1mmHg Pco2) (45).  
The formation of H2CO3 is catalysed by the enzyme carbonic anhydrase which is present at 
higher concentrations within RBCs. Thus, H2CO3 is generated in the RBC more than 10,000 
times faster. Consequently, the concentration of HCO3
-
 in RBCs rises in parallel. The RBC 
membrane itself is very permeable to HCO3
-
, allowing the latter to diffuse rapidly down the 
concentration gradient from the RBC to the plasma, depolarizing the RBC membrane, which, in 
turn, draws anions into the RBC from the plasma (75); the latter being mostly chloride ions (Cl
-
). 
The substitution of HCO3
-
 for Cl
-
 within the RBCs is labelled as the chloride shift (75). Increases 
in Pco2 enhance the production of HCO3
-
 without constraint, i.e. the CO2 dissociation curve does 
not have a plateau resembling the oxyhemoglobin dissociation curve. It is worthy to note that 
stem cells possess a superior level of antioxidant defence (206) which could also be the 
justification of their survival at the varying CO2 concentrations, where HSC are inclined to resist 
different micro-environmental conditions (59). 
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5.2 2D versus 3D 
The majority of cell-culture studies in the literature describe cell proliferation in flat 2D flasks 
with the notion of ‘bioreactors’ only recently emerging into the cell-culture field. In Experiment 
1, we showed that hypercapnia slows down proliferation and apoptosis of human BM 
promyeloblasts in 2D flasks. In Experiment 2, we described the 3D culturing of promyeloblasts 
in a stirred suspension bioreactor. No previous study, to the best of our knowledge, has described 
the 3D culturing of such cells under varying CO2 concentrations. This study is therefore novel in 
this respect. Moreover, no other study has examined the effect of CO2 on human promyeloblast 
apoptosis, cell surface antigens, nor glucose depletion.  
Table  5.1: Summary of identical experiments conducted at 15% CO2 in air in 2D and 3D 
systems, respectively 
 
Experiment 1 
2D 15% CO2  
Experiment 2 
3D 15% CO2 
Average Starting Cell 
Concentration (cells/ml) 
4.13  105  1.50  104 4.98  105  3.24  104 
Maximum Cell Concentration 
(cells/ml) 
5.09  106  3.13  105 4.18  106  3.51  104 
At Time (hours) 168 166 
Total Volume (ml) 8 ml 250 ml 
Total Cell Count (cells) 40.75  106 10.46  108 
PDT (hours) 44.5 43.3 
% SA at time -0.06 at 192 hours -0.68 at 190 hours 
 
In comparing Experiments 1 and 2, it can be seen that cell size in both cultures is comparable 
(Figures 4.2 and 4.6). Table 5.1 summarises the main aspects of both experiments (15% CO2 are 
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compared only). Maximum cell number at approximately the same time (168 hours and 166 
hours for 2D and 3D, respectively) is higher in the 2D culture, yet the overall cell count is much 
greater in the 3D system. This is due to the upscale in the bioreactor system with a total volume 
of 250 ml in contrast to the 8 ml of the 2D flasks. The 3D bioreactor systems are therefore more 
useful, under appropriately controlled conditions, for producing greater cell numbers in the same 
amount of time. The right bioreactor size is however expected to exist at a ‘sweet’ spot where 
differentiation does not occur. This question of bioreactor size, as well as the mode of bioreactor 
operation (eg. batch vs. continuous), are beyond the scope of this current work. 
The % SA is lower in the 3D culture system (-0.68 vs. -0.06), accompanied by a lower PDT 
(43.3 vs. 44.5). These results once again prove our hypotheses: (i) 3D bioreactor culture systems 
produce cells of greater quality (less apoptotic cells compared to the control), and (ii) the slower 
the cells double, the more guarded they are against DNA damage, the less the apoptotic capacity. 
It seems logic to conclude that our 3D culture system was successful in producing much greater 
numbers of high quality cells in the same amount of time as our 2D systems. 
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6. Chapter 6: Conclusions and 
Future Directions 
6.1 Toward an Understanding of How Hypercapnia Affects Apoptosis 
Researchers in the stem cell culturing field have almost completely overlooked CO2 in terms of 
mammalian stem cell proliferation and focused much more on the influences of O2 alone. 
Despite human blood containing an analogous 5% dissolved CO2, stem cells of the BM exist in a 
microenvironment of higher CO2 concentration (3-5). Hence, it seems illogic to assume this 5% 
CO2 for the proliferation of stem cells of the BM, but in fact, almost all cell proliferation systems 
in the literature do so. For this reason, our study’s aim was to analyse and investigate the effects 
of both hypo- and hypercapnia on the proliferation of hematopoietic progenitor stem cells (KG-
1a cell line). In addition, these cells’ apoptotic capacity, morphology, surface antigen integrity, 
and metabolism were also examined under these varying CO2 conditions. Furthermore, our work 
also highlighted the significance of culturing stem cells in 3D bioreactor vessels, contrary to 
conventional 2D ones. Once again, the 3D system provides greater similarity to the actual in vivo 
microenvironment of these cells. 
In more detail, we deduced from our study that KG-1a cells favour an environment of higher 
Pco2 and slightly lower pH where they proliferate slower (decreased PDT) and undergo 
apoptosis at a decreased rate (lower % SA) in contrast to the hypocapnic and control populations. 
These results were true in both 2D and 3D culture systems. The cell morphology (shape and size) 
was not affected by neither hypocapnia nor hypercapnia, following analysis by inverted 
microscope; however, after FCM analysis, it appeared that hypercapnic and control cells had 
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comparable cell surface antigen (CD34
+
) integrity in contrast to the hypocapnic ones which 
appeared to be impaired. Although the maximum cell concentration was greater in the 2D 
experiments compared to the 3D ones, it must be emphasized that the overall cell count is much 
greater in the 3D system since the total volume is over 30 times larger. Moreover, in our 3D 
populations, the increases in CO2 brought about decreases in the medium pH, which, as justified 
above, may be accountable for the apoptosis delay also seen in these populations. Finally, KG-1a 
cell metabolism rate (glucose depletion) decreased with an increase in %CO2; this agrees with 
the lower PDT seen for these hypercapnic populations. The overall conclusion is that although 
hematopoietic progenitor stem cells can be successfully maintained under atmospheric CO2 
pressures (5% in air); hypercapnic conditions seem to be advantageous for increased propagation 
and survival of hematopoietic progenitor stem cells. 
At this point, the cellular mechanism(s) by which hypercapnia delays apoptosis and increases 
cell proliferation is yet to be determined, we have only hypothesised what we think is reasonable 
relative to the available current literature: (i) the suppression of the production of ROS, which 
are the main stimulators of apoptosis, is accountable for the hindered apoptosis observed in the 
hypercapnic cells, (ii) the mitochondrial membrane stability/permeability in the acidified 
medium hinders apoptosis.  
This thesis analysed the effects of hypo- and hypercapnia using the cell line KG-1a as a model 
for human HSCs. Our study has illustrated that maintaining human KG-1a cells at elevated levels 
of CO2 brought about prolonged survival rates and increased overall proliferation, accompanied 
by decreased proliferation rates. Likewise, reduced levels of CO2 caused an increase in 
proliferation rates, but an overall decrease in KG-1a cell proliferation and an increase in 
apoptosis in comparison to the 5% CO2 control. HSCs are at present one of the predominant stem 
cell classes seen in modern, wide-scale clinical applications. Thus, growing HSCs into scalable 
quantities is potentially a huge advantage for both research and therapy. 
6.1.1 Future Work 
Due to time constraints, our experiments looked at only one hypercapnic condition (15% CO2), 
yet we were looking forward to completing a cell culture run at over 15%. It is worth saying that 
it is important to titrate the hypercapnic CO2 concentrations (lower and higher than 15%) in 
order to optimise the culture conditions, especially for the expansion of human hematopoietic 
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progenitor stem cells in vitro. Also, in order to validate these results further, it is important to 
evaluate what effects optimum hypercapnic conditions have on HSC phenotype, gene 
expression, and on animal models. Future studies will require a clearer understanding of the 
genes expressed in both hypo- and hypercapnic conditions, proteins involved in both conditions, 
and perhaps signalling pathways implicated. In addition, to further mimic the BM 
microenvironment of HSCs, the cell medium must also be modified accordingly through the 
supplementation of cytokines and/or other growth factors, for example. Finally, it would also be 
worthy to examine the hypo- and hypercapnic effects on other cell lines and then on actual 
human HSCs to further validate our results. 
Even after this research demonstrates that clinically meaningful numbers of human 
hematopoietic progenitors can be produced from an initial small inoculum of BM aspirate, there 
will remain further challenges to be conquered; such as, the addition of animal and/or human 
sera to the medium which may contain pathogens (116) – hence, the development of a substitute 
is crucial. This can either be the development of serum-free media (207) or the use of autologous 
plasma (208, 209), this topic has been reviewed in the literature (210, 211).  
Despite our mass efforts in pioneering the design and development of a 3D cell culture system, it 
is still however in its early stages. The bioreactor itself must be optimised in terms of parameters, 
such as: sheer stress, pressure, feed gas pressure within vessel, medium sampling, redox 
potential, etc. This is in order to better understand whether or not our observations were purely a 
result of hypercapnia or a combination of parameters.  
The next, and most important, phase is the development of a population balance model (PBM) 
which explicitly describes HSC proliferation in terms of: growth rate, overall cell number, 
division rate, cell death/apoptosis, dissolved gases (O2 and CO2), substrates (glutamine, glucose), 
metabolites (lactate, ammonia), and more. In addition, this model must take into account the 
bioreactor itself in terms of sheer stress and other hydrodynamic forces, as well as feeding into 
the cell medium and removal of waste products (in a continuously fed reactor), sampling out for 
analysis, and other factors. The model then requires validation (via several experimental runs) 
and coding. The model itself will then potentially serve as a means of dynamic optimisation for 
future bioreactor culture systems. Such an initiative could open new doors in HSCs research on 
one level and in stem cell biology overall on another level. 
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Moreover, the environment within the bioreactor itself must be optimised to further replicate the 
cellular microenvironment in terms of engineering. In other words, the BM niches are not a 
typical cylinder filled with liquid where cells grow and expand; it is much more complicated 
than that. The BM consists of smaller sub-compartments, pockets, surface areas for the cells to 
grow on, and other elements. Hence, a standard bioreactor on its own is inadequate and requires 
surfaces such as microcarriers, or beads, or matrices for the cells to proliferate on.  
We have begun working towards these objectives firstly by developing a PBM for the 
proliferation of HSCs in a 3D suspension bioreactor, and secondly by designing and creating 
(using 3D printing) a replica of the BM for cells to grow on within a bioreactor. In our group, 
Bartolini et al. recently developed a mathematical model for the 3D expansion of ESCs (212). 
The effects of varying substrate and gas concentration on total cell number were modelled. They 
found that with a high starting concentration of O2 in a fed-batch system, total cell number can 
be maximised. This model will be optimised further to include (i) the relationship between the 
%CO2 and the death kinetics (apoptosis rate) and (ii) the effects of multiple metabolites 
(glutamine, glucose, lactate, ammonia).  
6.2 Towards Autologous Transplantation – A future multi-scale systems 
approach in stem cell bioreactor operation 
Biological systems are composed of numerous complex scales that communicate information to 
and from strata above and below (213). The biological processes of these systems can be 
organised into a hierarchy of spatial scales: genes, to proteins, to individual cells, to tissues, to 
organs, and finally to the individual organism that interacts with its surrounding environment 
(214). 
Systems biology has been thoroughly investigated and developed over the last two decades with 
the aim of understanding biological behaviour at a global scale. These biological functions are 
the sum consequence of many complex mechanisms that occur at numerous scales: from the 
molecular to the ecosystem (215). In the context of stem cells and developmental biology, 
understanding how these growth systems are transformed with time is a key question yet to be 
answered. Existing experimental methods and techniques are still not competent enough in 
interpreting the various elements of these systems (216).  
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Mathematical modelling and simulation are computational tools that are at present modern being 
exploited for the comprehension, prediction, and portrayal of these mechanisms (natural or 
engineered mechanisms) by quantitative and integrative means (215). Successful analysis of 
these mechanisms must entail a clear understanding of the sub-interactions amongst the 
fundamental components of cells, organs, and systems in both the presence and the absence of 
disease (215). The construction of in-silico models has been used to generate experimental 
knowledge via software engineering methods (216). In other words, multi-scale techniques that 
permit the combining and simulation of models that span numerous spatial and temporal scales 
significantly promote the understanding of biological functions (215). The key method here is to 
incorporate known isolated mechanisms within simplified postulations where the knowledge is 
limited in order to analyse the developmental process (216, 217).  
Owing to the great complexity of biological systems, in-silico methods have proven promising in 
studying development and in guiding future experimental methods and techniques by predicting 
unexpected trends through the varying of the model’s design. Potentially, the investigation and 
the implementation of mathematical models could open many doors to scientists and researchers 
not only by summing up known and predicted results but also by highlighting innovative 
approachable predictions and ideas (216). Models and experimental data provide enormous 
information on the intra- and inter-scale interactions and behaviour within the system itself and 
as a whole with the environment (215). 
Mathematical models are utilised in continuum-based modelling techniques where mathematical 
equations or distinct modelling methods that are based on discrete units to model the 
heterogeneous microscopic elements (particulates or cells) are used to describe system properties 
(215). Models at the different scales must be coupled together in order to construct integrated 
models across these multiple scales to, in turn, achieve the objectives of systems biology entirely 
(215). In-silico models show great potential as common future techniques in both research and 
therapy. Today, many diverse models have been developed for solving multi-scale difficulties in 
various scientific disciplines and have been reviewed in the literature (215, 216). 
Multicellular organisms’ development, structure, and function are maintained by cell populations 
within developmental systems (218, 219). Development is controlled by the cells through two 
main procedures: (a) cellular proliferation in which the cell grows and divides to give rise to two 
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daughter cells, and (b) cellular differentiation through which an immature cell takes on a more 
specialized cell type/line (219). Knowledge of the precise cellular mechanisms and how these 
systems are regulated remain vague; even with all the state-of-the-art techniques, the picture that 
is drawn the experimental data continues to be somewhat deficient (216). Mathematical 
modelling has been increasingly applied to various biological systems (220); in fact, interest in 
this area is emerging and the various advances and challenges have been reviewed extensively 
(220-223). The majority of these studies are specific to a particular biological system (224-227); 
few others have attempted more generic methods (228, 229).  
Numerous models have been developed towards understanding cell population dynamics; other 
models identified expression patterns in stem cell systems development at the gene- and protein-
level (226, 230). Patterns of stem cell divisions and cell regulation in sub-systems were also 
simulated from mathematical models (231, 232). These works and the weakness they incorporate 
have been reviewed extensively by Setty et al. (216). One such weakness includes the limited 
ability of in-silico models to clearly represent the dynamics within the individual cells and to 
accurately predict spatial distributions of cells and complex phenotypes (216). The most 
common and the utmost limitation of the majority of previous modelling efforts is that 
development is only taken into account at the single-scale of the biological system and all other 
related scales are ignored. Hence, in order to achieve a rational understanding of the 
comprehensive development of cells in the tissue, there is a definite requirement for in-silico 
models that facilitate the incorporation of the regulation of sub-systems into a thorough/complete 
multi-scale dynamic mathematical model; such models have also been reviewed (216). 
Today, more bridges are being built between science and engineering where research is focusing 
more on applying in-silico modelling to various biological systems such as, stem cells. The many 
challenges and achievements in this area of multidisciplinary modelling were recently reviewed 
in several publications (219, 222, 223), but are beyond the scope of this dissertation.  
6.3 Population balance equations (PBE) 
Culturing any mammalian cell type involves accurate monitoring and control of in vitro 
physiological parameters during the cell culture. As discussed above, efficiency can be enhanced 
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by using mathematical models that predict population dynamics via the assimilation of kinetic 
data (cell size, cell numbers, cell death rate, metabolic uptake rates, differentiation rates…) (63). 
Population balance equations (PBEs) are a mathematical description of a population of elements 
derived from the interaction of a single element with its environment. They are employed in 
various fields of biomolecular engineering in order to optimise both growth and control of a 
particular cell line via the use of a PBM. The PBM can either be a single or an integration of 
several PBEs.  
In the case of stem cells, and in order to optimise their proliferation while maintaining their 
pluripotency, a great number of experiments must be conducted with varying culture conditions. 
This is not only uneconomic considering the high cost of cell culture materials, but also 
impractical bearing in mind the difficulties in obtaining stem cells in large numbers owing to 
strict ethics and policies. A PBM can then be used to enhance culture conditions in order to 
maximize results and minimize both time and experimental labour.  
A PBM represents a number balance based on the particle state. This particle state vector is the 
domain in which the particles expansion is continuous, but does not exceed the bounds of this 
domain. This state vector can be based on a different number of variables which is needed to 
describe the rate of change in the cells. Several state variables include cell age, cell mass, cell 
surface area etc. (233). 
PBMs can be classified as ‘unstructured’ or ‘structured’, and also as ‘segregated’ or 
‘unsegregated’. Unstructured population balances are less intricate than structured ones and 
employ a single state variable to illustrate the biophase in its environment. Structured population 
balances, however, singularly describe all the chemical components of this biophase by means of 
variables integrated into the PBE. On the other hand, an unsegregated model is based on the 
postulation that the cell population can be regarded as one constantly mixed biophase with no 
variations. A segregated model is again more complex and takes into account the heterogeneous 
nature of the cell expansion environment within the bioreactor. PBMs can also be defined as 
mass structured or age structured. The former have both mass and time amongst their variables 
and obey the law of conservation of mass, the latter employ the age of the individual cell as the 
variable in the population overall.  
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All PBMs illustrate the temporal dynamics of a population of particles with respect to the single 
particle, or single cell kinetics. A generalised form of the population balance of cells in a 
working 3D culture volume can be described by: 
Rate of cell accumulation = rate of cell birth + growth flux in − growth flux out − rate of cell 
division − rate of cell death (212) 
The cell kinetics include (refer to Bartolini et al. (212) for detailed equation formulations): 
 Occurrence of cell division 
 Probability at which the individual cells divide, differentiate, and/or die 
 State of newborn cells 
 Growth rate of individual cells 
In cell culture, in order to illustrate the entire cell property distributions, differentiation between 
the various cell states is initially required; hence the PBM must be segregated.  
6.4 Growth Models 
There are several different types of biological kinetics that can be attributed to cell growth for 
their use in PBMs or in logistic equations. These growth models are estimations of the rate at 
which cells will absorb mass from a substrate, usually only including one limiting substrate, 
unless rate constants (k) are used to define a number of different metabolite cycles. Some 
examples of the kinetics that can be used are reaction rate kinetics such as in Luni et al. where 
the reaction rates between receptor and ligand-receptor complex activation and deactivation are 
used as the single cell process kinetics (234). Another more complex method that is used in 
Hatzis et al. is the transition rate function for inter-stage transitions (235, 236). However, the 
most common kinetics that are used, are the simple Michaelis-Menten/Monod kinetics or 
variations of these kinetics, where the limiting substrate such as O2 is taken into account (237-
239). However, it is not usually dependent on other factors such as cell mass or surface area. In 
other cases where pluripotency is not sought the same kinetics can be attributed to limiting 
growth factors, where required for modelling differentiation (240). 
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6.5 Model-Based Control and Optimization of HSC Proliferation   
In order to better comprehend the physical, mechanical, and biochemical elements of stem cell 
culturing, analysis of both experiments and quantitative mathematical models are required. As 
mentioned above, a PBM should ideally be employed in such experiments to improve culture 
conditions in order to amplify results and reduce both time and experimental labour. This 
segment will now summarise and discuss works that have explored the model-based control and 
optimization of mammalian HSC expansion in 3D bioreactor systems.  
A few recent studies have been conducted on the proliferation and expansion of HSCs in 
bioreactors with an integrated PBE model. A review by Didwania et al. summarizes recent 
progress in developing a controlled artificial HSC niche in which current technologies for 
bioscaffold materials, microfluidic HSC niches and mathematical simulations of bioreactors 
were investigated (241). 
Peng and Palsson formulated a mathematical model of O2 diffusion, based on O2 uptake rate 
(OUR) data, which was subsequently used to investigate factors contributing to hematopoietic 
bioreactor design, such as initial seeding density, medium depth, reactor configuration, and O2 
partial pressure (242). Very high and very low levels of O2 can be harmful to cells causing 
toxicity and anoxia, respectively. Hence, a successful hematopoietic culture requires an optimal 
O2 concentration range. Based on this mathematical model and experimental data, the in situ 
OUR measurements matched predicted O2 limitations. Oxygen consumption was found to 
increase with culture time. The perfusion system used in this study for the expansion of BM cells 
was a radial-flow parallel-plate-type bioreactor and achieved a doubling in the number of cells 
over a 14-day culture period with a viability of 85-95% (242).  
Konstantinov et al. developed and experimentally tested a mathematical computer model of 
spheroid movement in commercially available rotating-vessel bioreactor system and a static 
bioreactor while considering all inertial effects caused by both the production module rotation 
movement and by the relative movement of the spheroid in the fluid. The group cultivated mouse 
hematopoietic BM cells and Hodgkin’s disease-derived malignant cells and tested both 
bioreactors’ efficacy to support long-term BM cell cultures. A nonlinear system of differential 
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equations was developed to describe dynamic behaviour and the growth was approximated using 
a limited linear function  
In addition, equations were suggested to describe the mechanical properties of cell spheroids 
which were approximated to elastic shear stress-sensitive bodies (106). The group reported a 
higher content of CFC-GM cells in the rotating-vessel system. The composed mathematical 
models of the physio-mechanical behaviour of spheroids facilitated the estimation of the 
revolution frequency increase schedule; the aim was to optimise the rotation frequency increase 
schedule for various cells to reduce shear stress, enhance productivity, and endure the expansion 
of large spheroids (106).  
Similarly, Pathi et al. investigated the role of nutrient supply on cell expansion in bioreactor 
design for cultivation of HSC. The group developed a mathematical model that quantitatively 
describes O2 levels in varying space and time and also simulates the growth of granulocyte 
progenitor cells alongside O2 consumption in a 3D perfusion bioreactor. They were able to 
deduce that maximum growth rates can be achieved based on a specific flow rate; flow rates 
higher or lower than this paramount lead to proliferation inhibition. The model further 
demonstrates the dependence of cell growth on O2 concentrations. The design of the reactor was 
also investigated via the model and was found to directly affect O2 distribution and thus cell 
growth; hence, an optimal bioreactor design must essentially include a large O2 distribution for 
maximized reactor yield (243). Further investigations on this topic can be found in the following 
reviews (22, 23, 69, 92, 107). 
Ma et al. developed a numerical model that examined the fluid flow, shear stress, and nutrient 
distribution with a purpose-built, porous scaffold placed within a 3D rotating wall perfused 
bioreactor. Although the group did not experimentally validate this work, the simulation results 
revealed that several factors are required to support optimal hematopoietic cell proliferation 
suitable for BMT applications; these factors include: fluid dynamics within the scaffold similar 
to those in the in vivo BM microenvironment, inoculum density, transport properties (scaffold), 
consumption rates, and spatial average O2 concentration within the vessel which ranged from 4% 
to 21% (244).  
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Kresnowati et. al. discussed the model-based analysis and optimization of bioreactor for HSC 
cultivation. The group explored the development of a mathematical model to describe the 
dynamics in nutrient distribution and cell concentration in a micro-channel perfusion fed-batch 
bioreactor. This model was then further utilised to optimise cell proliferation by proposing 
alternative feeding strategies. It is imperative to maintain equilibrium between feeding rate and 
cell requirement; overfeeding may result in nutrient and byproduct accumulation, whereas 
underfeeding will cause cell starvation and hence decreases expansion rates (91). The model was 
useful in illustrating alternative feeding strategies that improved cell yield. 
Doran et al. described the use of a simplified hollow fibre bioreactor system to produce blood 
products from umbilical CB-derived CD34
+
 HSPCs. Results were compared to cells cultured in 
the same optimised commercial medium in traditional static culture systems. Their results 
showed that although cell proliferation in the conventional cultures performed best, the 
simplified hollow fibre bioreactor system’s outcomes were almost equivalent in regards to total 
cell expansion and maturation. However, the simplified system employs significantly less protein 
and achieves an approximate 100-fold greater cell density (245). 
Glen et al. compared the production of blood cells from directly isolated CD34
+
 hematopoietic 
progenitor cells to equivalent cells that had been pre-expanded for a week with Delta1 Notch 
ligand. Cells were cultured under erythroid expansion and differentiation conditions in a micro-
scale suspension bioreactor with varying culture parameters. Growth trends were analysed 
through the measurement of phenotype markers and metabolites. The group found that erythroid 
differentiation chronology is somewhat controlled by the heterogeneous CD34
+
 progenitor 
compartment and that Delta1 ligand-mediated progenitor culture can modify cellular 
differentiation patterns (246). 
6.6 Conclusions and Future Remarks 
As presented above, very few studies in the literature provide sufficient information that 
evaluates the control and optimization of all parameters within a cell-culture system. In the 
majority of cases, complex kinetics are either overlooked, or the interaction between all 
parameters is ignored. The engineering of overall controlled systems for optimised HSC 
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cultivation is still in its early developmental stages and the application of PBE models to 3D 
bioreactor HSC culture systems has been limited to date. This is most likely due to the great 
intricacy in creating an exact, or close to exact, mimic of the in vivo microenvironment of stem 
cells niches (103). Relevant design parameters and physiochemical/biochemical parameters must 
be appreciated and investigated. These kinds of projects are multidisciplinary and require close 
integration of chemical and biomolecular/bioengineering, computer science, and medicine. 
The utmost goal in this field is to engineer systems that are not only very close replicas of the in 
vivo hematopoietic environment, especially in terms of gas composition, but also sufficient, 
simple, flexible, and of high economical efficacy. These systems can potentially be employed for 
HSC expansion at the bedside for cell therapy of leukaemia and other blood-related and non-
blood-related diseases. One major challenge is to increase both the productivity and the 
reliability of these hematopoietic ex vivo expansion systems by minimizing the number of initial 
cells required. The aim is to provide unlimited supplies of highly specialized cells for the 
purpose of stem cell therapy and tissue engineering as well as medical applications at the 
bedside. We believe our study has contributed 
For the future, we can expect to see the development of satisfactory, straightforward, highly 
productive and reliable HSC-culture systems. These systems will be tested in clinical studies and 
will eventually be used in transplantation therapies for leukaemia, but also for the production of 
many other types of highly specialized cells for the treatment of various other diseases. 
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8. Appendix I – Literature 
Review Summary Table 
 
Table A.1: Literature summary of Sections 2.6 and 2.7. This table summarises studies which 
examined the expansion of blood or blood-derived (human or murine) cell expansion in an either 
controlled or uncontrolled bioreactor system. 
Reference Culture Period Cell type Bioreactor 
Control type 
(uncontrolled, 
traditional 
control, model-
based control) 
Expansion 
(123) 12 weeks 
Human and rat 
BM 
Suspended 
nylon mesh 
system 
Uncontrolled - 
(124) 14-32 days TIL 
Hollow fibre 
(Cellmax) 
Uncontrolled 124-1170-fold 
(247) - 
LDMCs from 
human BM 
Stirred 
suspension  
Microcarrier 
Airlift 
Hollow Fibre 
Uncontrolled 4.4-32-fold 
(117) 4 weeks 
Cadaveric 
human BM 
cells 
Flat-bottomed 
stirred 
suspension 
spinner flask 
Uncontrolled 
Viable cells: 
16-fold 
CFC: 22-fold 
(125) 2 weeks 
Cadaveric 
human BM 
cells 
Flat-bottomed 
stirred 
suspension 
spinner flask 
Uncontrolled 
CFC: 45-66-
fold 
LTC-IC: 2.5-9-
fold 
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(119) 
14 days 
 
Mouse BM 
cells 
Stirred 
suspension 
Uncontrolled 
hematopoietic 
primitive 
progenitor cells: 
5-fold 
LTC-IC: 4-fold 
(126) - PB MNC 
Stirred 
suspension 
(spinner flasks) 
Uncontrolled - 
(127) 7 days PB MNC 
Stirred 
suspension 
(spinner flasks) 
Uncontrolled 
Total cells: 6-
fold 
(116) 14 days 
Human BM 
cells 
Stirred 
suspension 
(spinner flask) 
Uncontrolled 
Total cells: 
3.28-12.12-fold 
CFU-GM: 2.81-
9.25-fold 
(128) 12 days 
human 
umbilical CB 
HPC 
Stirred 
suspension 
(CultiSpher G) 
Uncontrolled 
TVC: 7.7-fold 
CFU-C: 23.3-
fold 
CD34
+
: 9.6-fold 
(129) 
6 days 
9 days 
CB HSCs 
Stirred 
suspension 
(stirred flasks) 
Uncontrolled 
CFC: 195.2  
24.6 g/cm
3
 
CD34+: 3.01  
0.26 g/cm
3
 
(130) 4 months 
Mouse BM 
cells 
Continuous 
perfusion 
Uncontrolled - 
(131) 14 days 
Human BM 
MNCs 
Perfusion Uncontrolled 
Total cells: 10-
fold 
LTC-IC: 7.5-
fold 
(132) 27 days 
Human BM 
cells 
Perfusion Uncontrolled 
Total cells: 
100-fold 
CFU-GM: 30-
fold 
(133) 7 days 
Human BM 
MNCs 
Perfusion Uncontrolled 
CFU-E: 
BFU-E: 
CFU-GM: 
CFU-GEMM: 
(134) 8 weeks 
Mouse BM 
cells 
Packed bed Uncontrolled - 
(136) 5 weeks 
Human BM 
cells 
Packed bed Uncontrolled - 
(137) 88  23 days Human TILs Hollow Fiber Uncontrolled 3  1010 cells 
(138) 8 days 
Human BM 
stroma HS-5 
Hollow Fiber Uncontrolled 
Total cells: 5.18 
 107 
Total CD34+: 
5.34  106 
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(139) 16-19 days 
Human BM 
cells 
Spinner flask Uncontrolled 
Total cells: 12-
24-fold 
(140) 7 days Human CB Spinner flask Uncontrolled 
Total cells: 
1.27-fold 
CD34+: 5.43-
fold 
CFC: 10.60-
fold 
(141) 12 days 
UCB-HSCs and 
UCB-MSCs 
RWVB Uncontrolled 
Total cell: (3.7 
 0.3)-fold 
CFU-C: (5.1   
1.2)-fold 
CD34
+
/CD45
+
/
CD105
-
 HSCs: 
(5.2  0.4)-fold 
CD34
-
/CD45
-
/CD105
+ 
MSCs: 
(13.9  1.2)-
fold 
(142) 7 days UCB RWVB Uncontrolled 
Total cells: 
(107.05  
6.08)-fold 
CD34+: (26.52 
 1.5)-fold 
CFU-C: (19.2  
3.18)-fold 
(143) 12 days 
Human CB 
MNCs 
RWVB Uncontrolled 
CBMC: (4.03  
0.71)-(4.41  
0.94)-fold 
(144) 3-6 weeks 
CD34+ 
hematopoietic 
progenitor cells 
from human 
BM 
CellFoam Uncontrolled - 
(145) 12 days UCB 
Dideco 
‘Pluricell 
System’ 
Uncontrolled 
MNC: 230.4  
91.5 
CD34+: 21.0  
11.9 
(248)  18 days 
CB cells 
unspecified 
Uncontrolled 
CD34+: 1.95  
10
6
-fold 
PB cells 
CD34+: 1.04  
10
5
-fold 
BM cells 
CD34+: 1.95  
10
5
-fold 
(146) 7 days CB 
Static + Cyclic 
Bioreactor 
Uncontrolled 
Total cells: 
(7.23 ± 2.67)-
fold 
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CD34+: (3.62  
0.65)-fold 
(147) 10 days UCB 
Bioreactor 
(other) 
Uncontrolled 
Total cells: 6.6-
45.7-fold 
 
(148) 12 days 
Human HSCs 
(CD34+) 
Stirred tank Uncontrolled 10-fold 
(150) 3-6 weeks 
Human and 
Murine BM 
cells 
Perfusion 
Traditional 
control 
Total cells: 5-
fold 
CFU-C: 10-fold 
Thy1.2
lo
 F4/80
-
 
MAC1
-
: 24-fold 
(151) 14 days 
Human BM 
cells 
Continuous 
perfusion 
Traditional 
control 
MNC: 20-25-
fold 
(152) 6 days UCB 
Continuous 
perfusion 
Traditional 
control 
CFU-GM: 40-
60-fold 
(152) 14 days MPB 
Continuous 
perfusion 
Traditional 
control 
Total cells: 50-
fold 
CFU-GM: 80-
fold 
LTC-IC: 20-
fold 
(153) 10 days PB MNCs 
Continuous 
perfusion 
Traditional 
control 
CFU-GM: 17-
19-fold 
(111) 8 days Human UCB 
Continuous 
perfusion: 
Fixed and 
fluidized bed 
Traditional 
control 
CFU-GEMM: 
4.2-fold 
CFU-GM: 7-
fold 
BFU-E: 1.8-
fold 
(154) 12 days 
Human BM 
MNCs 
Perfusion 
Traditional 
control 
Nucleated cells: 
4.9-fold 
CFU-GM: 9.5-
fold 
CD34
+
lin
-
: 
0.42-fold 
LTC-IC: 0.32-
fold 
(155) 12 days 
Human BM 
cells 
Perfusion 
Traditional 
control 
Total cells: 
3.32-4.94-fold 
CFU-GM: 0.52-
26.6-fold 
(156) 12 days 
Human BM 
cells 
Continuous 
perfusion 
Traditional 
control (?) 
MNC: 4.2-4.8-
fold 
CFU-GM: 11.0-
fold 
 133 
 
CFU-F: 43.1-
fold 
CD34
+
lin
-
: 0.9-
fold 
LTC-IC: 1.2-
fold 
(157) 12 days UCB 
Continuous 
perfusion 
Traditional 
control 
Viable cells: 
2.4-fold 
CFU-GM: 82.7-
fold 
CD34+: 0.5-
fold 
(158) - PB MNC 
Stirred 
suspension 
Traditional 
control 
- 
(159) - HL60 cells 
Stirred 
suspension 
Traditional 
control 
- 
(160) - HL60 cells 
Stirred 
suspension 
Traditional 
control 
- 
(161) - HL60 cells 
Stirred 
suspension 
Traditional 
control 
- 
(109) - UCB 
Stirred 
suspension 
Traditional 
control 
CFU-GM: 10-
fold 
CFU: 9.2-fold 
MNC: 14-fold 
(162) 10 days UCB cells 
Stirred 
suspension 
Traditional 
control 
Total cells: 6-
fold 
(163) - 
Murine BM 
cells 
Packed bed - - 
(164) 11 weeks Stromal cells Packed bed 
Traditional 
control 
BM cells: 3.6 x 
10
8
 cells 
(165) 8 days UCB RWVB 
Traditional 
control 
Total cells: 
(435.5±87.6)-
fold 
CD34+: 
(32.7±15.6)-
fold 
CFU-GM: 
(21.7±4.9)-
fold 
(166) 7 days Whole blood Hollow fiber - - 
(167) 7 days Whole blood Hollow fiber - - 
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(168) 7 days Whole blood Hollow fiber 
Traditional 
control 
- 
(169) 
7 days Umbilical CB 
and placenta-
derived stem 
cells 
Hollow fiber 
(2 ml) 
(8ml) Traditional 
control 
RBC: 105  33-
fold 
RBC: 440-fold 
19 days (8ml) 
RBC:14,288 -
fold 
(115) 14 days 
KG-1 
Human T cells 
CD34+ from 
CB 
Novel 
continuous 
perfused 
bioreactor 
Traditional 
control 
MNC: 18-fold 
CFC: 8-fold 
 14 days 
Novel fixed bed 
bioreactor 
Traditional 
control 
MNC: 100-fold 
CFU-GM: 114-
fold 
CAFC: 15-fold 
(170) 7 days UCB 
Microliter 
bioreactor 
array 
Traditional 
control 
Total cells: 
(17.1  2.6)-
fold 
(171) 6 days UCB 
Stirred 
Multiwell 
Bioreactor 
Traditional 
control 
CD34+: (96  
1)% 
CD38+: (86  
3)% 
CD117+: (77  
3)% 
CD41+: (99  
1)% 
CD61+: (4  
1)% 
(172) 
21 days 
UCB 
Wave agitated 
bioreactor 
(BIOSTAT 
CultiBag 
RM bioreactor) 
Traditional 
control 
1.73  106-fold 
33 days 2.25  108-fold 
(173) 16 days UCB - 
Traditional 
control 
CD34+: 130-
fold 
(242) 14 days 
Human BM 
cells 
Radial-flow 
parallel-plate-
type perfusion 
bioreactor 
Model-based 
control 
2-fold 
(106) - 
Murine 
hematopoietic 
BM cells 
Hodgkin’s 
disease-derived 
malignant cells 
rotating-vessel 
(miniPERM) 
Model-based 
control 
- 
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(243) - - Perfusion 
Model-based 
control 
- 
(244) 14 days - 
Rotating wall 
perfused 
Model-based 
control 
CFU-GM: 16-
fold 
(91) - - 
micro-channel 
perfusion 
Model-based 
control 
- 
(245) - UCB Hollow fiber 
Model-based 
control 
Total cells: 30-
fold 
(246) - 
CD34+ 
umbilical cord-
derived cells 
Stirred 
suspension 
(ambr micro-
scale 
bioreactor) 
Model-based 
control 
Total cells: 2.7 
 103-fold 
- : Information not reported 
*TIL: human tumour infiltrating lymphocytes 
*LDMC: low density mononuclear cells 
*CB: cord blood 
* hematopoietic progenitor cells 
*CFC: colony forming cell 
* bone marrow mononuclear cells 
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Publications  
i. Edoardo Bartolini, Harry Manoli, Eleonora Costamagna, Hari Athitha Jeyaseelan, Mouna 
Hamad, Mohammad R. Irhimeh, Ali Khademhosseini, Ali Abbas, Population balance 
modelling of stem cell culture in 3D suspension bioreactors. Chemical Engineering 
Research and Design (ChERD), 2015. 
 
ii. Mouna Hamad, Mohammad R. Irhimeh, Ali Abbas, Growth of Human KG-1a Stem Cells 
in Suspension Under Hypo- And Hypercapnic Conditions. Asian Pacific Confederation 
of Chemical Engineering, 2015.  
 
iii. Mouna Hamad, Mohammad R. Irhimeh, Ali Abbas, Hypercapnia slows down 
proliferation and apoptosis of human BM promyeloblasts. Bioprocess and Biosystems 
Engineering, 2016.  
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(Under internal review) 
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i. “Stem Cell Expansion Studies For the Treatment of Leukemia” Mouna Hamad, Ali 
 137 
 
Abbas; 3 Minute Thesis Faculty of Engineering and IT 2013: The University of 
Sydney, Sydney Australia, 10
th
 July, 2013 –Runner Up 
ii. “Stem Cell Expansion Studies For The Treatment Of Leukemia” Mouna Hamad, Ali 
Abbas; The NSW Joint Chemical Engineer Committee (JCEC) Annual Postgraduate 
Symposium 2013: Engineer Australia Chatswood, Sydney Australia, 30
th
 August, 2013 
– (Oral) First Place 
iii. “Stem Cell Expansion Studies For The Treatment Of Leukemia” Mouna Hamad, Ali 
Abbas; 5
th
 Annual Student Conference for Research Students 2013: The University of 
Sydney, Sydney Australia, 1
st
 October, 2013 – (Oral) First Place 
iv. “Modelling of Embryonic Stem Cell (ESC) Culture in 3D Suspension Bioreactors” 
Mouna Hamad, Harry Manoli, Ali Abbas; Research Conversazione 2013: The 
University of Sydney, Sydney Australia, 1st November, 2013 (Oral & Poster) First 
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